Doug Altman

• GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research

  Staniszewska S. et al, (2017), BMJ, 358

• Body composition at birth and its relationship with neonatal anthropometric ratios: the newborn body composition study of the INTERGROWTH-21st project.

  Villar J. et al, (2017), Pediatric research, 82, 305 - 316

• Associations Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization Trial.

  Taggart DP. et al, (2017), Circulation, 136, 454 - 463

• Invited commentary: methodological issues in the design and analysis of randomised trials.

  Mansournia MA. and Altman DG., (2017), British journal of sports medicine

• Enhancing the usability of systematic reviews by improving the consideration and description of interventions.

  Hoffmann TC. et al, (2017), BMJ (Clinical research ed.), 358

• Systematic review adherence to methodological or reporting quality.

  Pussegoda K. et al, (2017), Systematic reviews, 6

• Quality control of ultrasound for fetal biometry: results from the INTERGROWTH-21(st) Project.

  Cavallaro A. et al, (2017), Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

• Importance of the distinction between quality of methodology and quality of reporting.

  Altman DG. et al, (2017), HPB : The Official Journal of the International Hepato Pancreato Biliary Association, 19, 649 - 650

• CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.

  Boutron I. et al, (2017), Annals of internal medicine, 167, 40 - 47

• CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Traditional Chinese Version).

  Cheng CW. et al, (2017), Annals of internal medicine, 167, W7 - W20

• CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Simplified Chinese Version).

  Cheng CW. et al, (2017), Annals of internal medicine, 167, W21 - W34

• Support for reporting guidelines in surgical journals needs improvement: A systematic review.

  Agha RA. et al, (2017)

• CONSORT 2010 statement: extension checklist for reporting within person randomised trials.

  Pandis N. et al, (2017), BMJ : British Medical Journal, 357

• CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration.

  Cheng CW. et al, (2017), Annals of internal medicine

• The COMET Handbook: version 1.0.

  Williamson PR. et al, (2017), Trials, 18

• Identifying approaches for assessing methodological and reporting quality of systematic reviews: a descriptive study.

  Pussegoda K. et al, (2017), Systematic reviews, 6

• Choosing the target difference ('effect size') for a randomised controlled trial - DELTA2 guidance protocol.

  Cook JA. et al, (2017), Trials, 18

• Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study.

  Dechartres A. et al, (2017), BMJ, 357

• Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study.

  Dechartres A. et al, (2017), BMJ (Clinical research ed.), 357

• Assessing Agreement between Methods of Measurement.

  Altman DG. and Bland JM., (2017), Clinical chemistry

• Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.

  Kotecha D. et al, (2017), Journal of the American College of Cardiology, 69, 2885 - 2896

• CARE guidelines for case reports: explanation and elaboration document.

  Riley DS. et al, (2017), Journal of clinical epidemiology

• Characteristics and Dissemination of Phase 1 Trials Approved by a UK Regional Office in 2012.

  Odutayo A. et al, (2017), JAMA, 317, 1799 - 1801

• Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial†.

  Benedetto U. et al, (2017), European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

• Rating of Included Trials on the Efficacy-Effectiveness Spectrum: development of a new tool for systematic reviews.

  Wieland LS. et al, (2017), Journal of clinical epidemiology, 84, 95 - 104

• International estimated fetal weight standards of the INTERGROWTH-21st Project.

  Stirnemann J. et al, (2017), Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 49, 478 - 486

• Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials-ESORT).

  Odutayo A. et al, (2017), BMJ : British Medical Journal, 356

• Harms of outcome switching in reports of randomised trials: CONSORT perspective.

  Altman DG. et al, (2017), BMJ : British Medical Journal, 356

• The COMET Initiative database: progress and activities update (2015).

  Gargon E. et al, (2017), Trials, 18

• Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.

  Sekula P. et al, (2017), PloS one, 12

• CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials

  Schulz KF. et al, (2017), Japanese Pharmacology and Therapeutics, 45, 479 - 487

• AKI and Long-Term Risk for Cardiovascular Events and Mortality.

  Odutayo A. et al, (2017), Journal of the American Society of Nephrology : JASN, 28, 377 - 387

• The antepartum stillbirth syndrome: risk factors and pregnancy conditions identified from the INTERGROWTH-21st Project.

  Hirst JE. et al, (2016), BJOG : an international journal of obstetrics and gynaecology

• Review and publication of protocol submissions to Trials - what have we learned in 10 years?

  Li T. et al, (2016), Trials, 18

• Updating standards for reporting diagnostic accuracy: the development of STARD 2015

  Korevaar DA. et al, (2016), Research Integrity and Peer Review, 1

• Ultrasound-based gestational-age estimation in late pregnancy.

  Papageorghiou AT. et al, (2016), Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 48, 719 - 726

• Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.

  Kent DM. et al, (2016), International journal of epidemiology, 45, 2075 - 2088

• Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts.

  Taggart DP. et al, (2016), The New England journal of medicine, 375, 2540 - 2549

• Preterm feeding recommendations are achievable in large-scale research studies

  Cheikh Ismail L. et al, (2016), BMC Nutrition, 2

• Do declarative titles affect readers’ perceptions of research findings? A randomized trial

  Wager E. et al, (2016), Research Integrity and Peer Review, 1

• Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial.

  Hopewell S. et al, (2016), BMC medicine, 14

• No rationale for 1 variable per 10 events criterion for binary logistic regression analysis.

  van Smeden M. et al, (2016), BMC medical research methodology, 16

• STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

  Cohen JF. et al, (2016), BMJ open, 6

• International standards for symphysis-fundal height based on serial measurements from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: prospective cohort study in eight countries.

  Papageorghiou AT. et al, (2016), BMJ : British Medical Journal, 355

• Very large treatment effects in randomised trials as an empirical marker to indicate whether subsequent trials are necessary: meta-epidemiological assessment.

  Nagendran M. et al, (2016), BMJ : British Medical Journal, 355

• Reporting medical research

  Simera I. and Altman DG., (2016), Research Methods for Postgraduates, 429 - 439

• Randomised trials

  Altman DG., (2016), Research Methods for Postgraduates, 171 - 179

• CONSORT 2010 statement: extension to randomised pilot and feasibility trials.

  Eldridge SM. et al, (2016), BMJ : British Medical Journal, 355

• Core Outcome Set-STAndards for Reporting: The COS-STAR Statement.

  Kirkham JJ. et al, (2016), PLoS Medicine, 13

• ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

  Sterne JA. et al, (2016), BMJ : British Medical Journal, 355

• Terminal digit preference biases polyp size measurements at endoscopy, computed tomographic colonography, and histopathology.

  Plumb AA. et al, (2016), Endoscopy, 48, 899 - 908

• Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model.

  Collins GS. et al, (2016), Statistics in medicine, 35, 4124 - 4135

• Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings.

  Groenwold RH. et al, (2016), Journal of clinical epidemiology, 78, 90 - 100

• Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.

  Odutayo A. et al, (2016), BMJ : British Medical Journal, 354

• Systematic review of the methodological and reporting quality of case series in surgery.

  Agha RA. et al, (2016), The British journal of surgery, 103, 1253 - 1258

• Statistical analyses and methods in the published literature: the SAMPL guidelines

  Lang TA. and Altman DG., (2016), Medical Writing, 25

• Peer reviewers identified spin in manuscripts of nonrandomized studies assessing therapeutic interventions, but their impact on spin in abstract conclusions was limited.

  Lazarus C. et al, (2016), Journal of clinical epidemiology, 77, 44 - 51

• CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement.

  Vohra S. et al, (2016), Journal of clinical epidemiology, 76, 9 - 17

• CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration.

  Shamseer L. et al, (2016), Journal of clinical epidemiology, 76, 18 - 46

• Adequate sample size for developing prediction models is not simply related to events per variable.

  Ogundimu EO. et al, (2016), Journal of clinical epidemiology, 76, 175 - 182

• CARE: line guida per il reporting di casi clinici

  Gagnier JJ. et al, (2016), Evidence, 8

• Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: Insights from the Arterial Revascularization Trial.

  Benedetto U. et al, (2016), The Journal of thoracic and cardiovascular surgery, 152, 270 - 276

• Moderate Alcohol Intake and Cardiometabolic Risk in Adults With Type 2 Diabetes.

  Altman DG., (2016), Annals of internal medicine, 165, 67 - 68

• A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity.

  Yavchitz A. et al, (2016), Journal of clinical epidemiology, 75, 56 - 65

• Update on the endorsement of CONSORT by high impact factor journals: a survey of journal "Instructions to Authors" in 2014.

  Shamseer L. et al, (2016), Trials, 17

• External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges.

  Riley RD. et al, (2016), BMJ (Clinical research ed.), 353

• Statistical tests, P-values, confidence intervals, and power: a guide to misinterpretations

  Greenland S. et al, (2016), American Statistician, Online Supplement, 1 - 23

• Authors' reply to Cunningham and Messerli and colleagues.

  Kotecha D. et al, (2016), BMJ (Clinical research ed.), 353

• Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study.

  Page MJ. et al, (2016), PLoS medicine, 13

• Feasibility study to examine discrepancy rates in prespecified and reported outcomes in articles submitted to The BMJ.

  Weston J. et al, (2016), BMJ open, 6

• Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.

  Kotecha D. et al, (2016), BMJ (Clinical research ed.), 353

• Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.

  Greenland S. et al, (2016), European journal of epidemiology, 31, 337 - 350

• A systematic review of the methodological and reporting quality of case series in surgery

  Agha RA. et al, (2016), BRITISH JOURNAL OF SURGERY, 103, 32 - 33

• Improving the relevance and consistency of outcomes in comparative effectiveness research.

  Tunis SR. et al, (2016), Journal of comparative effectiveness research, 5, 193 - 205

• [Better Reporting of Interventions: Template for Intervention Description and Replication (TIDieR) Checklist and Guide].

  Hoffmann TC. et al, (2016), Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 78, 175 - 188

• The need for consensus, consistency, and core outcome sets in perioperative research.

  Blazeby JM. et al, (2016), Canadian journal of anaesthesia = Journal canadien d'anesthesie, 63, 133 - 137

• Reply to KL Stanhope and PJ Havel.

  Bland JM. and Altman DG., (2016), The American journal of clinical nutrition, 103

• PRISMA harms checklist: improving harms reporting in systematic reviews.

  Zorzela L. et al, (2016), BMJ : British Medical Journal, 352

• A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network.

  Altman DG. and Simera I., (2016), Journal of the Royal Society of Medicine, 109, 67 - 77

• STARD 2015: checklist aggiornata per il reporting degli studi di accuratezza diagnostica

  Bossuyt PM. et al, (2016), Evidence, 8

• Bias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensus.

  Bassler D. et al, (2016), BMJ open, 6

• Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey.

  Gorst SL. et al, (2016), PloS one, 11

• Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies.

  Emdin CA. et al, (2016), BMJ : British Medical Journal, 532

• Inverse probability weighting.

  Mansournia MA. and Altman DG., (2016), BMJ : British Medical Journal, 352

• Mixed-up confusion. Response to 'Freewheelin’ scientists: citing Bob Dylan in the biomedical literature', BMJ 2015;351:h6505

  Altman DG., (2016), BMJ

• Thanks to all those who reviewed for Trials in 2015.

  Altman DG. et al, (2016), Trials, 17

• Sparse data bias: a problem hiding in plain sight.

  Greenland S. et al, (2016), BMJ (Clinical research ed.), 352

• Sample size considerations for the external validation of a multivariable prognostic model: a resampling study.

  Collins GS. et al, (2016), Statistics in medicine, 35, 214 - 226

• Gestational weight gain standards based on women enrolled in the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: a prospective longitudinal cohort study.

  Cheikh Ismail L. et al, (2016), BMJ : British Medical Journal, 352

• CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials

  Schulz KF. et al, (2016), Japanese Pharmacology and Therapeutics, 44, 1375 - 1383

• CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials

  Schulz KF. et al, (2016), Japanese Pharmacology and Therapeutics, 44, 1061 - 1069

• CONSORT 2010 statement: extension to randomised pilot and feasibility trials.

  Eldridge SM. et al, (2016), Pilot and feasibility studies, 2

• Exploring the role and function of trial steering committees: results of an expert panel meeting.

  Harman NL. et al, (2015), Trials, 16

• STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.

  Bossuyt PM. et al, (2015), Clinical chemistry, 61, 1446 - 1452

• STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.

  Bossuyt PM. et al, (2015), Radiology, 277, 826 - 832

• SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

  Chan AW. et al, (2015), Revista panamericana de salud publica = Pan American journal of public health, 38, 506 - 514

• Deficiencies in the publication and reporting of the results of systematic reviews presented at scientific medical conferences.

  Hopewell S. et al, (2015), Journal of clinical epidemiology, 68, 1488 - 1495

• metan: fixed-and random-effects meta-analysis

  Harris RJ. et al, (2015), Meta-Analysis in Stata: An updated collection from the Stata Journal

• metan – a command for meta-analysis in Stata

  Bradburn MJ. et al, (2015), Meta-Analysis in Stata: An updated collection from the Stata Journal

• Postnatal growth standards for preterm infants: the Preterm Postnatal Follow-up Study of the INTERGROWTH-21(st) Project.

  Villar J. et al, (2015), The Lancet. Global health, 3, e681 - e691

• Best (but oft forgotten) practices: testing for treatment effects in randomized trials by separate analyses of changes from baseline in each group is a misleading approach.

  Bland JM. and Altman DG., (2015), The American journal of clinical nutrition, 102, 991 - 994

• STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies.

  Bossuyt PM. et al, (2015), BMJ : British Medical Journal, 351

• Systematic review of the methodological quality of studies designed to create neonatal anthropometric charts.

  Giuliani F. et al, (2015), Acta paediatrica (Oslo, Norway : 1992), 104, 987 - 996

• Reporting of a Publicly Accessible Protocol and Its Association With Positive Study Findings in Cardiovascular Trials (from the Epidemiological Study of Randomized Trials [ESORT]).

  Odutayo A. et al, (2015), The American journal of cardiology, 116, 1280 - 1283

• Monitoring human growth and development: a continuum from the womb to the classroom.

  Villar J. et al, (2015), American journal of obstetrics and gynecology, 213, 494 - 499

• Four Proposals to Help Improve the Medical Research Literature.

  Moher D. and Altman DG., (2015), PLoS Medicine, 12

• Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial.

  Barnes C. et al, (2015), BMC medicine, 13

• Some reflections on the evolution of meta-analysis.

  Altman DG., (2015), Research synthesis methods, 6, 265 - 267

• New Guideline for the Reporting of Studies Developing, Validating, or Updating a Multivariable Clinical Prediction Model: The TRIPOD Statement.

  Moons KG. et al, (2015), Advances in anatomic pathology, 22, 303 - 305

• Clinical trials: subgroup analyses in randomized trials--more rigour needed.

  Altman DG., (2015), Nature reviews. Clinical oncology, 12, 506 - 507

• The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].

  Travis SP. et al, (2015), Journal of Crohn's & colitis, 9, 607 - 616

• ISIS and the emergence of large, simple trials.

  Altman DG., (2015), Lancet (London, England), 386, 636 - 637

• Anthropometric Characterization of Impaired Fetal Growth: Risk Factors for and Prognosis of Newborns With Stunting or Wasting.

  Victora CG. et al, (2015), JAMA pediatrics, 169

• Family history and outcome of young patients with breast cancer in the UK (POSH study).

  Eccles BK. et al, (2015), The British journal of surgery, 102, 924 - 935

• Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform.

  Treweek S. et al, (2015), Trials, 16

• Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement.

  Collins GS. et al, (2015), European urology, 67, 1142 - 1151

• The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.

  Hutton B. et al, (2015), Annals of internal medicine, 162, 777 - 784

• The need for standardised outcomes in cancer clinical trials: a report of cancer core outcome sets

  Gargon E. et al, (2015), EUROPEAN JOURNAL OF CANCER CARE, 24, 10 - 10

• The effect of computer-aided detection markers on visual search and reader performance during concurrent reading of CT colonography.

  Helbren E. et al, (2015), European radiology, 25, 1570 - 1578

• The CONSORT Statement: Application within and adaptations for orthodontic trials.

  Pandis N. et al, (2015), American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics, 147, 663 - 679

• Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study.

  (2015), JACC. Cardiovascular imaging, 8, 656 - 665

• Effects of on-pump and off-pump surgery in the Arterial Revascularization Trial.

  Taggart DP. et al, (2015), European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 47, 1059 - 1065

• A systematic review of the use of an expertise-based randomised controlled trial design.

  Cook JA. et al, (2015), Trials, 16

• CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement.

  Vohra S. et al, (2015), BMJ : British Medical Journal, 350

• Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD).

  Collins GS. et al, (2015), Annals of internal medicine, 162, 735 - 736

• Major geographical variations in elective coronary revascularization by stents or surgery in England.

  Baig SS. et al, (2015), European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 47, 855 - 859

• INTERGROWTH-21st: describing optimal fetal growth, newborn size and postnatal growth and development for the improved phenotypic classification of the preterm birth and fetal growth restriction syndromes

  Hirst JE. et al, (2015), BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 122, 394 - 394

• Disadvantages of using the area under the receiver operating characteristic curve to assess imaging tests: a discussion and proposal for an alternative approach.

  Halligan S. et al, (2015), European radiology, 25, 932 - 939

• β blockers in patients with heart failure and atrial fibrillation - Authors' reply.

  Kotecha D. et al, (2015), Lancet (London, England), 385, 1618 - 1619

• Avoidable waste of research related to inadequate methods in clinical trials.

  Yordanov Y. et al, (2015), BMJ : British Medical Journal, 350

• The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention.

  Barros FC. et al, (2015), JAMA pediatrics, 169, 220 - 229

• NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.

  Chen JL. et al, (2015), International journal of cancer, 136, E590 - E601

• New guideline for the reporting of studies developing, validating, or updating a prediction model.

  Moons KG. et al, (2015), Clinical chemistry, 61, 565 - 566

• Making research articles fit for purpose: structured reporting of key methods and findings.

  Altman DG., (2015), Trials, 16

• Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.

  Collins GS. et al, (2015), European journal of clinical investigation, 45, 204 - 214

• Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.

  Collins GS. et al, (2015), Diabetic medicine : a journal of the British Diabetic Association, 32, 146 - 154

• Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement.

  Collins GS. et al, (2015), The British journal of surgery, 102, 148 - 158

• Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.

  Collins GS. et al, (2015), BJOG : an international journal of obstetrics and gynaecology, 122, 434 - 443

• Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.

  Collins GS. et al, (2015), Journal of clinical epidemiology, 68, 134 - 143

• Association of cardiovascular trial registration with positive study findings: Epidemiological Study of Randomized Trials (ESORT).

  Emdin C. et al, (2015), JAMA internal medicine, 175, 304 - 307

• The science of clinical practice: disease diagnosis or patient prognosis? Evidence about "what is likely to happen" should shape clinical practice.

  Croft P. et al, (2015), BMC medicine, 13

• Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials--ESORT).

  Emdin CA. et al, (2015), BMJ (Clinical research ed.), 350

• The natural history of conducting and reporting clinical trials: interviews with trialists.

  Smyth RM. et al, (2015), Trials, 16

• CONSORT 2010 Statement: Updated Guidelines for Reporting ParallelGroup Randomized Trials

  Schulz K. et al, (2015), Journal of Stomatology (Czasopismo Stomatologiczne), 67, 733 - 748

• Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers.

  Cook JA. et al, (2015), Trials, 16

• Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.

  Collins GS. et al, (2015), BMJ : British Medical Journal, 350

• Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.

  Collins GS. et al, (2015), British Journal of Cancer, 112, 251 - 259

• Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.

  Collins GS. et al, (2015), BMC medicine, 13

• Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group.

  Collins GS. et al, (2015), Circulation, 131, 211 - 219

• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

  Shamseer L. et al, (2015), BMJ : British Medical Journal, 349

• Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.

  Collins GS. et al, (2015), Annals of internal medicine, 162, 55 - 63

• Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

  Moons KG. et al, (2015), Annals of internal medicine, 162, W1 - 73

• The SPIRIT 2013 statement--defining standard protocol items for trials.

  Agha RA. et al, (2015), International journal of surgery (London, England), 13, 288 - 291

• The National Institutes of Health and guidance for reporting preclinical research.

  Moher D. et al, (2015), BMC medicine, 13

• The COMET initiative database: progress and activities update (2014).

  Gargon E. et al, (2015), Trials, 16

• Thanks to all those who reviewed for Trials in 2014.

  Altman DG. et al, (2015), Trials, 16

• Statistics Notes: Bootstrap resampling methods.

  Bland JM. and Altman DG., (2015), BMJ : British Medical Journal, 350

• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

  Moher D. et al, (2015), Systematic reviews, 4

• Obesity and the outcome of young breast cancer patients in the UK: the POSH study.

  Copson ER. et al, (2015), Annals of oncology : official journal of the European Society for Medical Oncology, 26, 101 - 112

• Is the relationship among outcome variables shown in randomized trials?

  Schriger DL. et al, (2015), Trials, 16

• Erratum: The National Institutes of Health and guidance for reporting preclinical research.

  Moher D. et al, (2015), BMC medicine, 13

• COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).

  Kirkham JJ. et al, (2015), Trials, 16

• CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration.

  Shamseer L. et al, (2015), BMJ : British Medical Journal, 350

• CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials

  Schulz KF. et al, (2015), Japanese Pharmacology and Therapeutics, 43, 883 - 891

• Basic statistical reporting for articles published in biomedical journals: the "Statistical Analyses and Methods in the Published Literature" or the SAMPL Guidelines.

  Lang TA. and Altman DG., (2015), International journal of nursing studies, 52, 5 - 9

• Assessment of the Incremental Benefit of Computer-Aided Detection (CAD) for Interpretation of CT Colonography by Experienced and Inexperienced Readers.

  Boone D. et al, (2015), PloS one, 10

• A systematic review protocol for reporting deficiencies within surgical case series.

  Agha R. et al, (2015), BMJ open, 5

• Tracking eye gaze during interpretation of endoluminal three-dimensional CT colonography: visual perception of experienced and inexperienced readers.

  Mallett S. et al, (2014), Radiology, 273, 783 - 792

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.

  von Elm E. et al, (2014), International journal of surgery (London, England), 12, 1495 - 1499

• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

  Vandenbroucke JP. et al, (2014), International journal of surgery (London, England), 12, 1500 - 1524

• STRengthening analytical thinking for observational studies: the STRATOS initiative.

  Sauerbrei W. et al, (2014), Statistics in medicine, 33, 5413 - 5432

• Scientific hypotheses can be tested by comparing the effects of one treatment over many diseases in a systematic review.

  Chen YF. et al, (2014), Journal of clinical epidemiology, 67, 1309 - 1319

• International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown-rump length in the first trimester of pregnancy.

  Papageorghiou AT. et al, (2014), Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 44, 641 - 648

• Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial.

  Boutron I. et al, (2014), Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32, 4120 - 4126

• Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.

  Kotecha D. et al, (2014), Lancet (London, England), 384, 2235 - 2243

• Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews.

  Saini P. et al, (2014), BMJ : British Medical Journal, 349

• Treatment Effect Heterogeneity in Clinical Trials: An Evaluation of 13 Large Clinical Trials Using Individual Patient Data.

  Kent DM. et al, (2014), Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17, A543 - A544

• Choosing Important Health Outcomes For Comparative Effectiveness Research: A Systematic Review.

  Gargon E. et al, (2014), Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17

• Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist.

  Moons KG. et al, (2014), PLoS medicine, 11

• The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional Study.

  Villar J. et al, (2014), The lancet. Diabetes & endocrinology, 2, 781 - 792

• Pragmatic trials can be designed as optimal medical care: principles and methods of care trials.

  Raymond J. et al, (2014), Journal of clinical epidemiology, 67, 1150 - 1156

• Fetal growth and ethnic variation--authors' reply.

  Villar J. et al, (2014), The lancet. Diabetes & endocrinology, 2, 774 - 775

• Detection of extracolonic pathologic findings with CT colonography: a discrete choice experiment of perceived benefits versus harms.

  Plumb AA. et al, (2014), Radiology, 273, 144 - 152

• ON- VS OFF CABG: EFFECTS ON POSTOPERATIVE LACTATE, BASE EXCESS AND PH OVER THE FIRST 24 HOURS IN INTENSIVE CARE

  Chiarenza F. et al, (2014), INTENSIVE CARE MEDICINE, 40, S61 - S61

• International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project.

  Papageorghiou AT. et al, (2014), Lancet (London, England), 384, 869 - 879

• International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project.

  Villar J. et al, (2014), Lancet (London, England), 384, 857 - 868

• Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach.

  Yi G. et al, (2014), Circulation, 130, 539 - 545

• Association between analytic strategy and estimates of treatment outcomes in meta-analyses.

  Dechartres A. et al, (2014), JAMA, 312, 623 - 630

• The COMET Initiative database: progress and activities from 2011 to 2013.

  Gargon E. et al, (2014), Trials, 15

• Improving the transparency of prognosis research: the role of reporting, data sharing, registration, and protocols.

  Peat G. et al, (2014), PLoS medicine, 11

• Response to Rezaeian: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) extension for ecological studies.

  Cevallos M. et al, (2014), Journal of clinical epidemiology, 67, 837 - 838

• Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study.

  Hopewell S. et al, (2014), BMJ : British Medical Journal, 349

• Coronary artery bypass grafting in high-RISk patients randomised to off- or on-Pump surgery: a randomised controlled trial (the CRISP trial).

  Rogers CA. et al, (2014), Health technology assessment (Winchester, England), 18, v - 157

• Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials.

  Dwan K. et al, (2014), PLoS medicine, 11

• Red blood cell transfusion and mortality in trauma patients: risk-stratified analysis of an observational study.

  Perel P. et al, (2014), PLoS Medicine, 11

• Use of methods for specifying the target difference in randomised controlled trial sample size calculations: Two surveys of trialists' practice.

  Cook JA. et al, (2014), Clinical trials (London, England), 11, 300 - 308

• PFM.49 Fetuses with gastroschisis have a reduced growth trajectory in the first half of gestation which normalises in late gestation.

  James C. et al, (2014), Archives of disease in childhood. Fetal and neonatal edition, 99 Suppl 1

• Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.

  Hislop J. et al, (2014), PLoS medicine, 11

• Towards a framework for analysis of eye-tracking studies in the three dimensional environment: a study of visual search by experienced readers of endoluminal CT colonography.

  Helbren E. et al, (2014), The British journal of radiology, 87

• RISK HETEROGENEITY IN CLINICAL TRIALS: AN EVALUATION OF 25 LARGE CLINICAL TRIALS USING INDIVIDUAL PATIENT DATA

  Kent DM. et al, (2014), VALUE IN HEALTH, 17, A190 - A190

• Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review.

  Cook JA. et al, (2014), Health technology assessment (Winchester, England), 18, v - 175

• Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation.

  Savović J. et al, (2014), Systematic reviews, 3

• The time has come to register diagnostic and prognostic research.

  Altman DG., (2014), Clinical chemistry, 60, 580 - 582

• External validation of multivariable prediction models: a systematic review of methodological conduct and reporting.

  Collins GS. et al, (2014), BMC medical research methodology, 14

• Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.

  Hoffmann TC. et al, (2014), BMJ : British Medical Journal, 348

• Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

  Kilkenny C. et al, (2014), Animals, 4, 35 - 44

• Reducing waste from incomplete or unusable reports of biomedical research.

  Glasziou P. et al, (2014), Lancet (London, England), 383, 267 - 276

• Uncertainty beyond sampling error.

  Altman DG. and Bland JM., (2014), BMJ : British Medical Journal, 349

• Uncertainty and sampling error.

  Altman DG. and Bland JM., (2014), BMJ : British Medical Journal, 349

• The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement.

  Hutton B. et al, (2014), PloS one, 9

• The CARE guidelines: consensus-based clinical case report guideline development.

  Gagnier JJ. et al, (2014), Journal of clinical epidemiology, 67, 46 - 51

• Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository.

  Tudur Smith C. et al, (2014), PloS one, 9

• Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review.

  Stevens A. et al, (2014), BMJ (Clinical research ed.), 348

• Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

  Moher D. et al, (2014), Revista Espanola de Nutricion Humana y Dietetica, 18, 172 - 181

• Multi-reader multi-case studies using the area under the receiver operator characteristic curve as a measure of diagnostic accuracy: systematic review with a focus on quality of data reporting.

  Dendumrongsup T. et al, (2014), PloS one, 9

• Linked publications from a single trial: a thread of evidence.

  Altman DG. et al, (2014), Trials, 15

• Korean translation of the CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials.

  Lee JS. et al, (2014), Epidemiology and health, 36

• Exploration of analysis methods for diagnostic imaging tests: problems with ROC AUC and confidence scores in CT colonography.

  Mallett S. et al, (2014), PloS one, 9

• Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study.

  Copson E. et al, (2014), British Journal of Cancer, 110, 230 - 241

• CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials

  Schulz KF. et al, (2014), Japanese Pharmacology and Therapeutics, 43, 265 - 273

• Choosing important health outcomes for comparative effectiveness research: a systematic review.

  Gargon E. et al, (2014), PloS one, 9

• Estimation of gestational age in early pregnancy from crown-rump length when gestational age range is truncated: the case study of the INTERGROWTH-21st Project.

  Ohuma EO. et al, (2013), BMC medical research methodology, 13

• The CARE guidelines: consensus-based clinical case report guideline development.

  Gagnier JJ. et al, (2013), Journal of dietary supplements, 10, 381 - 390

• The CARE guidelines: consensus-based clinical case reporting guideline development

  Gagnier JJ. et al, (2013), Journal of Medical Case Reports, 7

• A population-based survival analysis describing the association of body mass index on time to revision for total hip and knee replacements: results from the UK general practice research database.

  Culliford D. et al, (2013), BMJ open, 3

• Effect of Bilateral Internal Mammary Artery on Long-Term Survival: A Meta-analysis Approach

  Yi G. et al, (2013), CIRCULATION, 128

• The CARE guidelines: consensus-based clinical case reporting guideline development.

  Gagnier JJ. et al, (2013), Headache, 53, 1541 - 1547

• Reliability and initial validation of the ulcerative colitis endoscopic index of severity.

  Travis SP. et al, (2013), Gastroenterology, 145, 987 - 995

• Fetal biometry: how well can offline measurements from three-dimensional volumes substitute real-time two-dimensional measurements?

  Sarris I. et al, (2013), Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 42, 560 - 570

• The CARE guidelines: consensus-based clinical case reporting guideline development

  Gagnier JJ. et al, (2013), Case Reports, 2013, bcr2013201554 - bcr2013201554

• The CARE guidelines: consensus-based clinical case reporting guideline development.

  Gagnier JJ. et al, (2013), Deutsches Arzteblatt international, 110, 603 - 608

• The objectives, design and implementation of the INTERGROWTH-21st Project.

  Villar J. et al, (2013), BJOG : an international journal of obstetrics and gynaecology, 120 Suppl 2, 9 - v

• The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development.

  Gagnier JJ. et al, (2013), Global advances in health and medicine, 2, 38 - 43

• Statistical considerations for the development of prescriptive fetal and newborn growth standards in the INTERGROWTH-21st Project.

  Altman DG. and Ohuma EO., (2013), BJOG : an international journal of obstetrics and gynaecology, 120 Suppl 2, 71 - v

• Standardisation and quality control of ultrasound measurements taken in the INTERGROWTH-21st Project.

  Sarris I. et al, (2013), BJOG : an international journal of obstetrics and gynaecology, 120 Suppl 2, 33 - v

• Managing data for the international, multicentre INTERGROWTH-21st Project.

  Ohuma EO. et al, (2013), BJOG : an international journal of obstetrics and gynaecology, 120 Suppl 2, 64 - v

• In defence of logarithmic transformations.

  Bland JM. et al, (2013), Statistics in medicine, 32, 3766 - 3768

• Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas).

  Collins GS. and Altman DG., (2013), The British journal of general practice : the journal of the Royal College of General Practitioners, 63, e636 - e642

• A rapid questionnaire assessment of environmental exposures to pregnant women in the INTERGROWTH-21st Project.

  Eskenazi B. et al, (2013), BJOG : an international journal of obstetrics and gynaecology, 120 Suppl 2, 129 - v

• Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews.

  Gagnier JJ. et al, (2013), BMC medical research methodology, 13

• Declaration of transparency for each research article.

  Altman DG. and Moher D., (2013), BMJ : British Medical Journal, 347

• Transparent reporting of trials is essential.

  Altman DG., (2013), The American journal of gastroenterology, 108, 1231 - 1235

• Reporting medical research.

  Simera I. and Altman DG., (2013), International journal of clinical practice, 67, 710 - 716

• Reporting characteristics of non-primary publications of results of randomized trials: a cross-sectional review.

  Hopewell S. et al, (2013), Trials, 14

• Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.

  Copson E. et al, (2013), Journal of the National Cancer Institute, 105, 978 - 988

• Identifying women with undetected ovarian cancer: independent and external validation of QCancer(®) (Ovarian) prediction model.

  Collins GS. and Altman DG., (2013), European journal of cancer care, 22, 423 - 429

• Birmingham and Lambeth Liver Evaluation Testing Strategies (BALETS): a prospective cohort study

  Lilford RJ. et al, (2013), HEALTH TECHNOLOGY ASSESSMENT, 17, 1 - +

• IDEAL framework for surgical innovation 1: the idea and development stages.

  McCulloch P. et al, (2013), BMJ (Clinical research ed.), 346

• IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages.

  Ergina PL. et al, (2013), BMJ (Clinical research ed.), 346

• The benefits and harms of breast cancer screening: an independent review.

  Marmot MG. et al, (2013), British journal of cancer, 108, 2205 - 2240

• Method for tracking eye gaze during interpretation of endoluminal 3D CT colonography: technical description and proposed metrics for analysis.

  Phillips P. et al, (2013), Radiology, 267, 924 - 931

• Reporting noninferiority trials--reply.

  Pocock SJ. et al, (2013), JAMA, 309

• Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model.

  Collins GS. and Altman DG., (2013), Cancer epidemiology, 37, 115 - 120

• Design flaws in EuroSCORE II.

  Collins GS. and Altman DG., (2013), European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 43

• The benefits and harms of breast cancer screening Reply

  Marmot MG. et al, (2013), LANCET, 381, 803 - 804

• External validation of a Cox prognostic model: principles and methods.

  Royston P. and Altman DG., (2013), BMC medical research methodology, 13

• Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysis.

  Bala MM. et al, (2013), Journal of clinical epidemiology, 66, 286 - 295

• Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal).

  Collins GS. and Altman DG., (2013), European journal of cancer (Oxford, England : 1990), 49, 1040 - 1048

• Calibration of EuroSCORE II.

  Collins GS. and Altman DG., (2013), European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 43

• Adjustment for continuous confounders: an example of how to prevent residual confounding.

  Groenwold RH. et al, (2013), CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 185, 401 - 406

• Independent UK Panel on Breast Cancer Screening replies to Michael Baum.

  Marmot M. et al, (2013), BMJ : British Medical Journal, 346

• Prognosis research strategy (PROGRESS) 4: stratified medicine research.

  Hingorani AD. et al, (2013), BMJ (Clinical research ed.), 346

• Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes.

  Hemingway H. et al, (2013), BMJ (Clinical research ed.), 346

• SPIRIT 2013 statement: defining standard protocol items for clinical trials.

  Chan AW. et al, (2013), Annals of internal medicine, 158, 200 - 207

• Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.

  Calvert M. et al, (2013), JAMA, 309, 814 - 822

• Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design.

  Kotecha D. et al, (2013), Systematic reviews, 2

• SPIRIT 2013: new guidance for content of clinical trial protocols.

  Chan AW. et al, (2013), Lancet (London, England), 381, 91 - 92

• SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

  Chan AW. et al, (2013), BMJ : British Medical Journal, 346

• The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration.

  Turner L. et al, (2013), Systematic reviews, 2

• Statistics notes: missing outcomes in randomised trials.

  Vickers AJ. and Altman DG., (2013), BMJ (Clinical research ed.), 346

• Prognosis Research Strategy (PROGRESS) 2: prognostic factor research.

  Riley RD. et al, (2013), PLoS medicine, 10

• Prognosis Research Strategy (PROGRESS) 3: prognostic model research.

  Steyerberg EW. et al, (2013), PLoS Medicine, 10

• PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts.

  Beller EM. et al, (2013), PLoS medicine, 10

• Patients' & healthcare professionals' values regarding true- & false-positive diagnosis when colorectal cancer screening by CT colonography: discrete choice experiment.

  Boone D. et al, (2013), PloS one, 8

• Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional study.

  Hopewell S. et al, (2013), BMJ open, 3

• Data sharing among data monitoring committees and responsibilities to patients and science.

  Chalmers I. et al, (2013), Trials, 14

• ASSESSING RISK OF BIAS IN RANDOMISED CLINICAL TRIALS INCLUDED IN COCHRANE REVIEWS: THE WHY IS EASY, THE HOW IS A CHALLENGE

  Hrobjartsson A. et al, (2013), COCHRANE DATABASE OF SYSTEMATIC REVIEWS

• Presentation of continuous outcomes in randomised trials: an observational study.

  Schriger DL. et al, (2012), BMJ : British Medical Journal, 345

• Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

  Piaggio G. et al, (2012), JAMA, 308, 2594 - 2604

• Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review.

  Turner L. et al, (2012), Systematic reviews, 1

• Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.

  Turner L. et al, (2012), The Cochrane database of systematic reviews, 11

• The benefits and harms of breast cancer screening: an independent review.

  (2012), Lancet (London, England), 380, 1778 - 1786

• Improving the reporting of randomised trials: the CONSORT Statement and beyond.

  Altman DG. et al, (2012), Statistics in medicine, 31, 2985 - 2997

• QRISK2-2011 predicted cardiovascular disease in adult general practice patients

  Collins GS. and Altman DG., (2012), Annals of Internal Medicine, 157

• Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach.

  Wright S. et al, (2012), Trials, 13

• Core outcome sets and the COMET (core outcome measures in effectiveness trials) initiative; improving the efficiency and value of the research process

  Blazeby J. et al, (2012), QUALITY OF LIFE RESEARCH, 21, 19 - 20

• CONSORT PRO 2012: translating guidance to practice

  Calvert M. et al, (2012), QUALITY OF LIFE RESEARCH, 21, 83 - 83

• Consort 2010 statement: extension to cluster randomised trials.

  Campbell MK. et al, (2012), BMJ : British Medical Journal, 345

• Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.

  Savović J. et al, (2012), Health technology assessment (Winchester, England), 16, 1 - 82

• Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.

  Savović J. et al, (2012), Annals of internal medicine, 157, 429 - 438

• Adherence of trials of operative intervention to the CONSORT statement extension for non-pharmacological treatments: a comparative before and after study.

  Gray R. et al, (2012), Annals of the Royal College of Surgeons of England, 94, 388 - 394

• Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis.

  Groenwold RH. et al, (2012), CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 184, 1265 - 1269

• Interpreting diagnostic accuracy studies for patient care.

  Mallett S. et al, (2012), BMJ (Clinical research ed.), 345

• Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK.

  Collins GS. and Altman DG., (2012), Heart (British Cardiac Society), 98, 1091 - 1097

• Identifying patients with undetected colorectal cancer: an independent validation of QCancer (Colorectal).

  Collins GS. and Altman DG., (2012), British journal of cancer, 107, 260 - 265

• Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.

  Collins GS. and Altman DG., (2012), BMJ : British Medical Journal, 344

• Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children.

  Sinha IP. et al, (2012), Pediatrics, 129 Suppl 3, S146 - S152

• Standard 4: determining adequate sample sizes.

  van der Tweel I. et al, (2012), Pediatrics, 129 Suppl 3, S138 - S145

• Standard 3: data monitoring committees.

  Ellenberg S. et al, (2012), Pediatrics, 129 Suppl 3, S132 - S137

• Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

  Altman DG. et al, (2012), BMC medicine, 10

• Does journal endorsement of reporting guidelines influence the completeness of reporting of health research? A systematic review protocol.

  Shamseer L. et al, (2012), Systematic reviews, 1

• Risk prediction models: II. External validation, model updating, and impact assessment.

  Moons KG. et al, (2012), Heart (British Cardiac Society), 98, 691 - 698

• Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker.

  Moons KG. et al, (2012), Heart (British Cardiac Society), 98, 683 - 690

• Reporting clinical research: guidance to encourage accurate and transparent research reporting.

  Simera I. et al, (2012), Maturitas, 72, 84 - 87

• Off-pump vs. on-pump CABG: are we any closer to a resolution?

  Taggart DP. and Altman DG., (2012), European heart journal, 33, 1181 - 1183

• Predicting the risk of chronic kidney disease in the UK: an evaluation of QKidney® scores using a primary care database.

  Collins G. and Altman D., (2012), The British journal of general practice : the journal of the Royal College of General Practitioners, 62, e243 - e250

• Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

  Kilkenny C. et al, (2012), Osteoarthritis and cartilage, 20, 256 - 260

• Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).

  Travis SP. et al, (2012), Gut, 61, 535 - 542

• Credibility of claims of subgroup effects in randomised controlled trials: systematic review.

  Sun X. et al, (2012), BMJ : British Medical Journal, 344

• Systematic review: bias in imaging studies - the effect of manipulating clinical context, recall bias and reporting intensity.

  Boone D. et al, (2012), European radiology, 22, 495 - 505

• Intra- and interobserver variability in fetal ultrasound measurements.

  Sarris I. et al, (2012), Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 39, 266 - 273

• Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

  Kilkenny C. et al, (2012), Veterinary clinical pathology, 41, 27 - 31

• Sample size calculations for designing clinical proteomic profiling studies using mass spectrometry.

  Nyangoma SO. et al, (2012), Statistical applications in genetics and molecular biology, 11, Article - 2

• The basis for monitoring strategies in clinical guidelines: a case study of prostate-specific antigen for monitoring in prostate cancer.

  Dinnes J. et al, (2012), CMAJ : Canadian Medical Association Journal, 184, 169 - 177

• Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice.

  Stewart GB. et al, (2012), PloS one, 7

• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

  Altman DG. et al, (2012), PLoS medicine, 9

• Reporting and methods in clinical prediction research: a systematic review.

  Bouwmeester W. et al, (2012), PLoS medicine, 9, 1 - 12

• Prediction of moderate and high grade vesicoureteral reflux after a first febrile urinary tract infection in children: construction and internal validation of a clinical decision rule.

  Leroy S. et al, (2012), The Journal of urology, 187, 265 - 271

• Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review.

  Akl EA. et al, (2012), BMJ (Clinical research ed.), 344

• Driving up the quality and relevance of research through the use of agreed core outcomes.

  Williamson P. et al, (2012), Journal of health services research & policy, 17, 1 - 2

• Distinguishing case series from cohort studies.

  Dekkers OM. et al, (2012), Annals of internal medicine, 156, 37 - 40

• Developing core outcome sets for clinical trials: issues to consider.

  Williamson PR. et al, (2012), Trials, 13

• CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

  Moher D. et al, (2012), International journal of surgery (London, England), 10, 28 - 55

• Building a metaphor: another brick in the wall?

  Altman DG., (2012), BMJ : British Medical Journal, 345

• Authors' reply to Bird.

  Collins GS. and Altman DG., (2012), BMJ, 345

• Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals.

  Hirst A. and Altman DG., (2012), PloS one, 7

• Agreed statistics: measurement method comparison.

  Bland JM. and Altman DG., (2012), Anesthesiology, 116, 182 - 185

• Comparisons against baseline within randomised groups are often used and can be highly misleading.

  Bland JM. and Altman DG., (2011), Trials, 12

• Standardization of fetal ultrasound biometry measurements: improving the quality and consistency of measurements.

  Sarris I. et al, (2011), Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 38, 681 - 687

• Reporting of effect direction and size in abstracts of systematic reviews.

  Beller EM. et al, (2011), JAMA, 306, 1981 - 1982

• The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

  Higgins JP. et al, (2011), BMJ : British Medical Journal, 343

• Reply:

  Raymond J. et al, (2011), American Journal of Neuroradiology, 32, E181 - E181

• Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.

  Sterne JA. et al, (2011), BMJ : British Medical Journal, 343

• Describing reporting guidelines for health research: a systematic review.

  Moher D. et al, (2011), Journal of clinical epidemiology, 64, 718 - 742

• Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.

  Collins GS. et al, (2011), BMJ : British Medical Journal, 342

• External validation of QDSCORE(®) for predicting the 10-year risk of developing Type 2 diabetes.

  Collins GS. and Altman DG., (2011), Diabetic medicine : a journal of the British Diabetic Association, 28, 599 - 607

• Assessing prognosis from nonrandomized studies: an example from brain arteriovenous malformations.

  Raymond J. et al, (2011), AJNR. American journal of neuroradiology, 32, 809 - 812

• Resources for authors of reports of randomized trials: harnessing the wisdom of authors, editors, and readers.

  Moher D. et al, (2011), Trials, 12

• The problem of subgroup analyses: an example from a trial on ruptured intracranial aneurysms.

  Naggara O. et al, (2011), AJNR. American journal of neuroradiology, 32, 633 - 636

• Preferred reporting items of systematic review and meta-analyses: the PRISMA statement

  Moher D. et al, (2011), DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 136, E25 - E25

• CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

  Schulz KF. et al, (2011), DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 136, E26 - E26

• Animal research: reporting in vivo experiments--the ARRIVE guidelines.

  Kilkenny C. et al, (2011), Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 31, 991 - 993

• Correlation in restricted ranges of data

  Bland JM. and Altman DG., (2011), BMJ, 342, d556 - d556

• Biomarker studies: a call for a comprehensive biomarker study registry.

  Andre F. et al, (2011), Nature reviews. Clinical oncology, 8, 171 - 176

• Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms.

  Naggara O. et al, (2011), AJNR. American journal of neuroradiology, 32, 437 - 440

• CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials RESPONSE

  Schulz KF. et al, (2011), ANNALS OF INTERNAL MEDICINE, 154, 291 - 292

• Use of the Internet by print medical journals in 2003 to 2009: a longitudinal observational study.

  Schriger DL. et al, (2011), Annals of emergency medicine, 57, 153 - 160.e3

• Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed.

  Dechartres A. et al, (2011), Journal of clinical epidemiology, 64, 136 - 144

• Incremental benefit of computer-aided detection when used as a second and concurrent reader of CT colonographic data: multiobserver study.

  Halligan S. et al, (2011), Radiology, 258, 469 - 476

• Comparison of protocols and registry entries to published reports for randomised controlled trials.

  Dwan K. et al, (2011), The Cochrane database of systematic reviews

• Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists.

  Smyth RM. et al, (2011), BMJ (Clinical research ed.), 342

• Uses and misuses of the STROBE statement: bibliographic study.

  da Costa BR. et al, (2011), BMJ open, 1

• Reporting of participant flow diagrams in published reports of randomized trials.

  Hopewell S. et al, (2011), Trials, 12

• PRISMA statement.

  Moher D. et al, (2011), Epidemiology (Cambridge, Mass.), 22

• Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study.

  Song F. et al, (2011), BMJ (Clinical research ed.), 343

• How to obtain the P value from a confidence interval.

  Altman DG. and Bland JM., (2011), BMJ (Clinical research ed.), 343

• How to obtain the confidence interval from a P value.

  Altman DG. and Bland JM., (2011), BMJ (Clinical research ed.), 343

• Five years of Trials.

  Altman DG. et al, (2011), Trials, 12

• Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial.

  Cobo E. et al, (2011), BMJ (Clinical research ed.), 343

• CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

  Schulz KF. et al, (2011), International journal of surgery (London, England), 9, 672 - 677

• Comparisons within randomised groups can be very misleading.

  Bland JM. and Altman DG., (2011), BMJ (Clinical research ed.), 342

• Brackets (parentheses) in formulas.

  Altman DG. and Bland JM., (2011), BMJ (Clinical research ed.), 343

• Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling study.

  Marshall A. et al, (2010), BMC medical research methodology, 10

• CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials

  Schulz KF. et al, (2010), Italian Journal of Public Health, 7, 325 - 332

• From trial to practice Authors' reply

  Glasziou P. et al, (2010), BRITISH MEDICAL JOURNAL, 341

• Visualizing and assessing discrimination in the logistic regression model.

  Royston P. and Altman DG., (2010), Statistics in medicine, 29, 2508 - 2520

• Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement.

  MacPherson H. et al, (2010), Journal of alternative and complementary medicine (New York, N.Y.), 16, ST1 - S14

• Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART).

  Taggart DP. et al, (2010), European heart journal, 31, 2470 - 2481

• Improving bioscience research reporting: ARRIVE-ing at a solution.

  Kilkenny C. and Altman DG., (2010), Laboratory animals, 44, 377 - 378

• CONSORT 2010 comments.

  Schulz KF. et al, (2010), Lancet (London, England), 376, 1222 - 1223

• Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement

  MacPherson H. et al, (2010), Medical Acupuncture, 22, 167 - 180

• Randomized Controlled Trials With Statistically Nonsignificant Results Reply

  Boutron I. et al, (2010), JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 304, 965 - 965

• Prediction of High-Grade Vesico-Ureteral Reflux after a First Urinary Tract Infection in Children: Construction and Internal Validation of a Clinical Decision Rule

  Leroy S. et al, (2010), PEDIATRIC NEPHROLOGY, 25, 1852 - 1852

• CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials

  Schulz KF. et al, (2010), Open Medicine, 4

• [Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement (Chinese version)].

  Hugh M. et al, (2010), Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 8, 804 - 818

• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (Chinese version)

  Moher D., (2010), Journal of Chinese Integrative Medicine, 701 - 741

• Taking healthcare interventions from trial to practice.

  Glasziou P. et al, (2010), BMJ (Clinical research ed.), 341

• Statistical methods for assessing agreement between two methods of clinical measurement

  Bland JM. and Altman DG., (2010), INTERNATIONAL JOURNAL OF NURSING STUDIES, 47, 931 - 936

• Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement.

  MacPherson H. et al, (2010), Journal of evidence-based medicine, 3, 140 - 155

• CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.

  Schulz KF. et al, (2010), Journal of clinical epidemiology, 63, 834 - 840

• CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.

  Moher D. et al, (2010), Journal of clinical epidemiology, 63, e1 - 37

• Animal research: reporting in vivo experiments: the ARRIVE guidelines.

  Kilkenny C. et al, (2010), British journal of pharmacology, 160, 1577 - 1579

• Animal research: reporting in vivo experiments: the ARRIVE guidelines.

  (2010), Experimental physiology, 95, 842 - 844

• Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research.

  Kilkenny C. et al, (2010), Journal of pharmacology & pharmacotherapeutics, 1, 94 - 99

• Development of a combined database for meta-epidemiological research.

  Savović J. et al, (2010), Research synthesis methods, 1, 212 - 225

• Animal research: reporting in vivo experiments: the ARRIVE guidelines.

  Kilkenny C. et al, (2010), The journal of gene medicine, 12, 561 - 563

• [CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (Chinese version)].

  Schulz KF. et al, (2010), Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 8, 604 - 612

• Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

  Kilkenny C. et al, (2010), PLoS biology, 8

• Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement.

  MacPherson H. et al, (2010), Acupuncture in medicine : journal of the British Medical Acupuncture Society, 28, 83 - 93

• Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement.

  MacPherson H. et al, (2010), PLoS medicine, 7

• CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.

  Schulz KF. et al, (2010), Annals of internal medicine, 152, 726 - 732

• Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review.

  Yu LM. et al, (2010), Trials, 11

• An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.

  Collins GS. and Altman DG., (2010), BMJ : British Medical Journal, 340

• Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.

  Boutron I. et al, (2010), JAMA, 303, 2058 - 2064

• CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.

  Schulz KF. et al, (2010), Obstetrics and gynecology, 115, 1063 - 1070

• Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network.

  Simera I. et al, (2010), BMC medicine, 8

• Forest plots in reports of systematic reviews: a cross-sectional study reviewing current practice.

  Schriger DL. et al, (2010), International journal of epidemiology, 39, 421 - 429

• Effect size estimation as an essential component of statistical analysis.

  Vedula SS. and Altman DG., (2010), Archives of surgery (Chicago, Ill. : 1960), 145, 401 - 402

• CONSORT 2010 changes and testing blindness in RCTs.

  Schulz KF. et al, (2010), Lancet (London, England), 375, 1144 - 1146

• Reporting performance of prognostic models in cancer: a review.

  Mallett S. et al, (2010), BMC medicine, 8

• Reporting methods in studies developing prognostic models in cancer: a review.

  Mallett S. et al, (2010), BMC medicine, 8

• CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

  Schulz KF. et al, (2010), PLoS medicine, 7

• CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.

  Schulz KF. et al, (2010), Trials, 11

• The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed.

  Hopewell S. et al, (2010), BMJ : British Medical Journal, 340

• Bias due to changes in specified outcomes during the systematic review process.

  Kirkham JJ. et al, (2010), PloS one, 5

• Guidance for developers of health research reporting guidelines.

  Moher D. et al, (2010), PLoS medicine, 7

• The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews.

  Kirkham JJ. et al, (2010), BMJ : British Medical Journal, 340

• Development and validation of a prediction model with missing predictor data: a practical approach.

  Vergouwe Y. et al, (2010), Journal of clinical epidemiology, 63, 205 - 214

• Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers.

  Hrynaszkiewicz I. et al, (2010), Trials, 11

• Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers.

  Hrynaszkiewicz I. et al, (2010), BMJ (Clinical research ed.), 340

• Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study.

  Marshall A. et al, (2010), BMC medical research methodology, 10

• Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study.

  Nüesch E. et al, (2010), BMJ (Clinical research ed.), 341

• Responsible reporting of health research studies: transparent, complete, accurate and timely.

  Altman DG. and Simera I., (2010), The Journal of antimicrobial chemotherapy, 65, 1 - 3

• Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.

  Mallett S. et al, (2010), British Journal of Cancer, 102, 173 - 180

• REPORTING OF CONTINUOUS OUTCOME MEASURES IN RANDOMIZED CLINICAL TRIALS: IS THE WHOLE STORY BEING TOLD?

  Savage DF. et al, (2010), JOURNAL OF INVESTIGATIVE MEDICINE, 58, 175 - 176

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  Moher D. et al, (2010), International journal of surgery (London, England), 8, 336 - 341

• Inadequate post-publication review of medical research.

  Schriger DL. and Altman DG., (2010), BMJ (Clinical research ed.), 341

• CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.

  Schulz KF. et al, (2010), BMC medicine, 8

• CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

  Schulz KF. et al, (2010), BMJ (Clinical research ed.), 340

• CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

  Moher D. et al, (2010), BMJ (Clinical research ed.), 340

• Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal.

  Kent DM. et al, (2010), Trials, 11

• A catalogue of reporting guidelines for health research.

  Simera I. et al, (2010), European journal of clinical investigation, 40, 35 - 53

• Ten steps towards improving prognosis research.

  Hemingway H. et al, (2009), BMJ : British Medical Journal, 339

• The effects of exclusions of patients from the analysis in randomised controlled trials: Meta-epidemiological study

  Nüesch E. et al, (2009), Deutsches Arzteblatt, 106

• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration

  Liberati A. et al, (2009), Italian Journal of Public Health, 6, 354 - 391

• The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study.

  Nüesch E. et al, (2009), Arthritis and rheumatism, 61, 1633 - 1641

• Kontakt til udvalgene for videnskabelig uredelighed er det logiske skridt: Svar

  Gøtzsche PC. et al, (2009), Ugeskrift for Laeger, 171

• Survey of the quality of experimental design, statistical analysis and reporting of research using animals.

  Kilkenny C. et al, (2009), PloS one, 4

• Writing a research article that is "fit for purpose": EQUATOR Network and reporting guidelines.

  Simera I. and Altman DG., (2009), Evidence-based medicine, 14, 132 - 134

• Which activity index for ulcerative colitis? evaluation of the size and effect of inter_observer variation in clinical, endoscopic and composite indices

  Walsh AJ. et al, (2009), JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, A321 - A321

• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

  Liberati A. et al, (2009), Journal of clinical epidemiology, 62, e1 - 34

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  Moher D. et al, (2009), Journal of clinical epidemiology, 62, 1006 - 1012

• How variable is the mayo score between obnservers and might this affect trial recruitment or outcome?

  Walsh AJ. et al, (2009), JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, A230 - A230

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Chinese edition)

  Moher D., (2009), Journal of Chinese Integrative Medicine, 7, 889 - 896

• The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study.

  Nüesch E. et al, (2009), BMJ : British Medical Journal, 339

• Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  Moher D. et al, (2009), Physical therapy, 89, 873 - 880

• Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory.

  Hróbjartsson A. et al, (2009), Journal of clinical epidemiology, 62, 967 - 973

• QRISK validation and evaluation Authors' reply

  Collins GS. and Altman DG., (2009), BRITISH MEDICAL JOURNAL, 339

• No surgical innovation without evaluation: the IDEAL recommendations.

  McCulloch P. et al, (2009), Lancet (London, England), 374, 1105 - 1112

• Comparison of registered and published primary outcomes in randomized controlled trials.

  Mathieu S. et al, (2009), JAMA, 302, 977 - 984

• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

  Liberati A. et al, (2009), Annals of internal medicine, 151, W65 - W94

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  Moher D. et al, (2009), Annals of internal medicine, 151, 264 - W64

• ACP Journal Club. Editorial: Writing a research article that is "fit for purpose": EQUATOR Network and reporting guidelines.

  Simera I. and Altman DG., (2009), Annals of internal medicine, 151, JC2 - JC3

• Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines.

  Marshall A. et al, (2009), BMC medical research methodology, 9

• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

  Liberati A. et al, (2009), PLoS medicine, 6

• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

  Liberati A. et al, (2009), BMJ : British Medical Journal, 339

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  Moher D. et al, (2009), BMJ (Clinical research ed.), 339

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  Moher D. et al, (2009), PLoS medicine, 6

• An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.

  Collins GS. and Altman DG., (2009), BMJ (Clinical research ed.), 339

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies

  Von Elm E. et al, (2009), UroToday International Journal, 2

• Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration

  Boutron I. et al, (2009), Journal of Chinese Integrative Medicine, 7, 690 - 699

• Missing outcomes in randomized trials: Addressing the dilemma

  Altman DG., (2009), Open Medicine, 3

• Assessing new methods of clinical measurement.

  Altman DG., (2009), The British Journal of General Practice, 59, 399 - 400

• The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studies.

  Simera I. et al, (2009), Maturitas, 63, 4 - 6

• Protocols, probity, and publication.

  Schulz KF. et al, (2009), Lancet (London, England), 373

• Extending the CONSORT statement to randomized trials of nonpharmacologic treatment; explanation and elaboration

  Boutron I. et al, (2009), Journal of Chinese Integrative Medicine, 7, 491 - 494

• A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

  Thorpe KE. et al, (2009), CMAJ : Canadian Medical Association Journal, 180, E47 - E57

• A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

  Thorpe KE. et al, (2009), Journal of clinical epidemiology, 62, 464 - 475

• Analysis of continuous data from small samples.

  Bland JM. and Altman DG., (2009), BMJ : British Medical Journal, 338

• WHICH ACTIVITY INDEX FOR ULCERATIVE COLITIS? EVALUATION OF INTER-OBSERVER VARIATION IN CLINICAL, ENDOSCOPIC AND COMPOSITE INDICES

  Walsh AJ. et al, (2009), GUT, 58, A15 - A15

• Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.

  Riley RD. et al, (2009), British Journal of Cancer, 100, 1219 - 1229

• Improving the reporting of pragmatic trials: An extension of the CONSORT statement

  Zwarentein M. et al, (2009), Journal of Chinese Integrative Medicine, 7, 392 - 397

• Videnskabelig uredelighed

  Gøtzsche PC. et al, (2009), Ugeskrift for Laeger, 171

• Prognostic models: a methodological framework and review of models for breast cancer.

  Altman DG., (2009), Cancer investigation, 27, 235 - 243

• [Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration].

  Vandenbroucke JP. et al, (2009), Gaceta sanitaria, 23

• Improving the quality of reporting acupuncture interventions: describing the collaboration between STRICTA, CONSORT and the Chinese Cochrane Centre.

  MacPherson H. and Altman DG., (2009), Journal of evidence-based medicine, 2, 57 - 60

• Towards agreement on best practice for publishing raw clinical trial data.

  Hrynaszkiewicz I. and Altman DG., (2009), Trials, 10

• Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials.

  Sun X. et al, (2009), Trials, 10

• Prognosis and prognostic research: validating a prognostic model.

  Altman DG. et al, (2009), BMJ (Clinical research ed.), 338

• Prognosis and prognostic research: Developing a prognostic model.

  Royston P. et al, (2009), BMJ (Clinical research ed.), 338

• Prognosis and prognostic research: what, why, and how?

  Moons KG. et al, (2009), BMJ (Clinical research ed.), 338

• Prognosis and prognostic research: application and impact of prognostic models in clinical practice.

  Moons KG. et al, (2009), BMJ : British Medical Journal, 338

• Parametric v non-parametric methods for data analysis.

  Altman DG. and Bland JM., (2009), BMJ (Clinical research ed.), 338

• Models for potentially biased evidence in meta-analysis using empirically based priors

  Welton NJ. et al, (2009), JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 172, 119 - 136

• Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews.

  Song F. et al, (2009), BMJ (Clinical research ed.), 338

• LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact.

  Akl EA. et al, (2009), Trials, 10

• Design, analysis, and presentation of crossover trials.

  Mills EJ. et al, (2009), Trials, 10

• Improving the reporting of pragmatic trials: an extension of the CONSORT statement.

  Zwarenstein M. et al, (2008), BMJ (Clinical research ed.), 337

• Composite outcomes in cardiovascular research: a survey of randomized trials.

  Lim E. et al, (2008), Annals of internal medicine, 149, 612 - 617

• Improving the clarity and transparency of reporting health research: a shared obligation and responsibility.

  Needleman I. et al, (2008), Journal of dental research, 87, 894 - 895

• Special Topics in Statistics

  Higgins JP. et al, (2008), 481 - 529

• Assessing Risk of Bias in Included Studies

  Higgins JP. and Altman DG., (2008), 187 - 241

• Analysing Data and Undertaking Meta-Analyses

  Deeks JJ. et al, (2008), 243 - 296

• Key issues in conducting a meta-analysis of gene expression microarray datasets.

  Ramasamy A. et al, (2008), PLoS medicine, 5

• Modelling prognostic factors in advanced pancreatic cancer.

  Stocken DD. et al, (2008), British journal of cancer, 99, 883 - 893

• Re: Visualizing length of survival in time-to-event studies: A complement to Kaplan-Meier plots - Response

  Royston P. et al, (2008), JOURNAL OF THE NATIONAL CANCER INSTITUTE, 100, 1188 - 1189

• EQUATOR: Reporting guidelines for health research

  Altman DG. et al, (2008), Open Medicine, 2

• Reporting bias in diagnostic and prognostic studies: time for action.

  Rifai N. et al, (2008), Clinical chemistry, 54, 1101 - 1103

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting of observational studies

  von Elm E. et al, (2008), NOTFALL & RETTUNGSMEDIZIN, 11, 260 - 265

• Guidelines for reporting health research: the EQUATOR network's survey of guideline authors.

  Simera I. et al, (2008), PLoS medicine, 5

• [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies].

  von Elm E. et al, (2008), Der Internist, 49, 688 - 693

• Measurement of colonic polyps by radiologists and endoscopists: who is most accurate?

  Punwani S. et al, (2008), European radiology, 18, 874 - 881

• [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies].

  von Elm E. et al, (2008), Revista espanola de salud publica, 82, 251 - 259

• Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'.

  Hopewell S. et al, (2008), Trials, 9

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  von Elm E. et al, (2008), Journal of clinical epidemiology, 61, 344 - 349

• EQUATOR: reporting guidelines for health research.

  Altman DG. et al, (2008), Lancet (London, England), 371, 1149 - 1150

• Efficacy of Selective Serotonin Reuptake Inhibitors (SSRIS) compared to placebo in obsessive compulsive disorder in adults

  Soomro GM. et al, (2008), EUROPEAN PSYCHIATRY, 23, S220 - S221

• Systematic Reviews of Evaluations of Prognostic Variables

  Altman DG., (2008), Systematic Reviews in Health Care: Meta-Analysis in Context: Second Edition, 228 - 247

• Systematic Reviews in Health Care: Meta-Analysis in Context: Second Edition

  Egger M. et al, (2008), 1 - 487

• Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

  Deeks JJ. et al, (2008), Systematic Reviews in Health Care: Meta-Analysis in Context: Second Edition, 285 - 312

• Effect Measures for Meta-Analysis of Trials with Binary Outcomes

  Deeks JJ. and Altman DG., (2008), Systematic Reviews in Health Care: Meta-Analysis in Context: Second Edition, 313 - 335

• Assessing the Quality of Randomised Controlled Trials

  Jüni P. et al, (2008), Systematic Reviews in Health Care: Meta-Analysis in Context: Second Edition, 87 - 108

• Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

  Wood L. et al, (2008), BMJ (Clinical research ed.), 336, 601 - 605

• [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies].

  von Elm E. et al, (2008), Gaceta sanitaria, 22, 144 - 150

• [CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration].

  Hopewel S. et al, (2008), Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 6, 221 - 232

• Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.

  Boutron I. et al, (2008), Annals of internal medicine, 148, W60 - W66

• Improving the completeness and transparency of reports of randomized trials in oral health: the CONSORT statement.

  Needleman I. et al, (2008), American journal of dentistry, 21, 7 - 12

• Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.

  Boutron I. et al, (2008), Annals of internal medicine, 148, 295 - 309

• CT colonography: a systematic review of standard of reporting for studies of computer-aided detection.

  Robinson C. et al, (2008), Radiology, 246, 426 - 433

• Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).

  Soomro GM. et al, (2008), The Cochrane database of systematic reviews

• Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots.

  Royston P. et al, (2008), Journal of the National Cancer Institute, 100, 92 - 97

• The EQUATOR Network: facilitating transparent and accurate reporting of health research

  Simera I., (2008), Serials: The Journal for the Serials Community, 21, 183 - 187

• Systematic review of the empirical evidence of study publication bias and outcome reporting bias.

  Dwan K. et al, (2008), PloS one, 3

• Reporting of clinical trials: a review of research funders' guidelines.

  Dwan K. et al, (2008), Trials, 9

• metan: fixed- and random-effects meta-analysis

  Harris RJ. et al, (2008), STATA JOURNAL, 8, 3 - 28

• Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research.

  Moher D. et al, (2008), BMC medicine, 6

• Ensuring trial validity by data quality assurance and diversification of monitoring methods.

  Baigent C. et al, (2008), Clinical trials (London, England), 5, 49 - 55

• Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols.

  Chan AW. et al, (2008), BMJ (Clinical research ed.), 337

• CONSORT for reporting randomised trials in journal and conference abstracts.

  Hopewell S. et al, (2008), Lancet (London, England), 371, 281 - 283

• CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.

  Hopewell S. et al, (2008), PLoS medicine, 5

• Evaluation of the Ages and Stages Questionnaires in identifying children with neurosensory disability in the Magpie Trial follow-up study.

  Yu LM. et al, (2007), Acta paediatrica (Oslo, Norway : 1992), 96, 1803 - 1808

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  von Elm E. et al, (2007), Epidemiology (Cambridge, Mass.), 18, 800 - 804

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  von Elm E. et al, (2007), Bulletin of the World Health Organization, 85, 867 - 872

• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

  Vandenbroucke JP. et al, (2007), Epidemiology (Cambridge, Mass.), 18, 805 - 835

• Commentary: strengthening the reporting of observational epidemiology the STROBE statement.

  Egger M. et al, (2007), International journal of epidemiology, 36, 948 - 950

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  von Elm E. et al, (2007), Preventive medicine, 45, 247 - 251

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  von Elm E. et al, (2007), PLoS medicine, 4

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  von Elm E. et al, (2007), Annals of internal medicine, 147, 573 - 577

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  von Elm E. et al, (2007), Lancet (London, England), 370, 1453 - 1457

• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  von Elm E. et al, (2007), BMJ (Clinical research ed.), 335, 806 - 808

• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

  Vandenbroucke JP. et al, (2007), PLoS medicine, 4

• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

  Vandenbroucke JP. et al, (2007), Annals of internal medicine, 147, W163 - W194

• Prognosis research: toward evidence-based results and a Cochrane methods group.

  Riley RD. et al, (2007), Journal of clinical epidemiology, 60, 863 - 865

• Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.

  Pildal J. et al, (2007), International journal of epidemiology, 36, 847 - 857

• Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data.

  Trivella M. et al, (2007), The Lancet. Oncology, 8, 488 - 499

• Masking or blinding? Blinding is better than masking

  Schulz KF. et al, (2007), BRITISH MEDICAL JOURNAL, 334, 918 - 918

• Evidence-based practice in radiology: steps 3 and 4--appraise and apply systematic reviews and meta-analyses.

  Halligan S. and Altman DG., (2007), Radiology, 243, 13 - 27

• The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months

  Duley L. et al, (2007), BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 114, 289 - 299

• The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years

  Duley L. et al, (2007), BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 114, 300 - 309

• Simulation studies of surrogate endpoint validation using single trial and multitrial statistical approaches.

  Lassere M. et al, (2007), The Journal of rheumatology, 34, 616 - 619

• Epidemiology and reporting characteristics of systematic reviews.

  Moher D. et al, (2007), PLoS Medicine, 4

• Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.

  Lassere MN. et al, (2007), The Journal of rheumatology, 34, 607 - 615

• Missing data.

  Altman DG. and Bland JM., (2007), BMJ (Clinical research ed.), 334

• The use of the World Wide Web by medical journals in 2003 and 2005: an observational study.

  Schriger DL. et al, (2007), Pediatrics, 119, e53 - e60

• Systematic review of multiple studies of prognosis: The feasibility of obtaining individual patient data

  Altman DG. et al, (2007), 3 - 18

• Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol.

  Eccles D. et al, (2007), BMC cancer, 7

• Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation.

  Cooney RM. et al, (2007), Trials, 8

• Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting.

  Szarewski A. et al, (2007), Journal of medical screening, 14, 34 - 42

• Ghost authorship in industry-initiated randomised trials.

  Gøtzsche PC. et al, (2007), PLoS medicine, 4

• Effect of directed training on reader performance for CT colonography: multicenter study.

  (2007), Radiology, 242, 152 - 161

• Agreement between methods of measurement with multiple observations per individual.

  Bland JM. and Altman DG., (2007), Journal of biopharmaceutical statistics, 17, 571 - 582

• The design of simulation studies in medical statistics.

  Burton A. et al, (2006), Statistics in medicine, 25, 4279 - 4292

• The content of medical journal Instructions for authors.

  Schriger DL. et al, (2006), Annals of emergency medicine, 48, 743 - 749.e4

• From submission to publication: a retrospective review of the tables and figures in a cohort of randomized controlled trials submitted to the British Medical Journal.

  Schriger DL. et al, (2006), Annals of emergency medicine, 48, 750 - 756.21

• Computed tomographic colonography: assessment of radiologist performance with and without computer-aided detection.

  Halligan S. et al, (2006), Gastroenterology, 131, 1690 - 1699

• The Oxford Conception Study design and recruitment experience.

  Pyper C. et al, (2006), Paediatric and perinatal epidemiology, 20 Suppl 1, 51 - 59

• Systematic reviews of clinical decision tools for acute abdominal pain.

  Liu JL. et al, (2006), Health technology assessment (Winchester, England), 10, 1 - iv

• REporting recommendations for tumor MARKer prognostic studies (REMARK).

  McShane LM. et al, (2006), Breast cancer research and treatment, 100, 229 - 235

• Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review.

  Plint AC. et al, (2006), The Medical journal of Australia, 185, 263 - 267

• Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

  Williams C. et al, (2006), Health technology assessment (Winchester, England), 10, iii - 204

• Systematic reviews of diagnostic tests in cancer: review of methods and reporting.

  Mallett S. et al, (2006), BMJ (Clinical research ed.), 333

• Polyp measurement and size categorisation by CT colonography: effect of observer experience in a multi-centre setting.

  Burling D. et al, (2006), European radiology, 16, 1737 - 1744

• CT colonography interpretation times: effect of reader experience, fatigue, and scan findings in a multi-centre setting.

  Burling D. et al, (2006), European radiology, 16, 1745 - 1749

• Polyp measurement using CT colonography: agreement with colonoscopy and effect of viewing conditions on interobserver and intraobserver agreement.

  Burling D. et al, (2006), AJR. American journal of roentgenology, 186, 1597 - 1604

• The cost of dichotomising continuous variables.

  Altman DG. and Royston P., (2006), BMJ (Clinical research ed.), 332

• Research protocols: waiving confidentiality for the greater good.

  Chan AW. et al, (2006), BMJ : British Medical Journal, 332, 1086 - 1089

• Constraints on publication rights in industry-initiated clinical trials.

  Gøtzsche PC. et al, (2006), JAMA, 295, 1645 - 1646

• Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].

  Taggart DP. et al, (2006), Trials, 7

• Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

  Piaggio G. et al, (2006), JAMA, 295, 1152 - 1160

• Decision tools in health care: focus on the problem, not the solution.

  Liu J. et al, (2006), BMC medical informatics and decision making, 6

• Lead editorial: trials - using the opportunities of electronic publishing to improve the reporting of randomised trials.

  Altman DG. et al, (2006), Trials, 7

• Evidence-based assessment and application of prognostic markers: The long way from single studies to meta-analysis

  Sauerbrei W. et al, (2006), COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 35, 1333 - 1342

• Dichotomizing continuous predictors in multiple regression: a bad idea.

  Royston P. et al, (2006), Statistics in medicine, 25, 127 - 141

• Re: Reporting recommendations for tumor marker prognostic studies (REMARK) - Reply

  McShane LM. et al, (2005), JOURNAL OF THE NATIONAL CANCER INSTITUTE, 97, 1855 - 1856

• Reporting recommendations for tumor marker prognostic studies.

  McShane LM. et al, (2005), Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23, 9067 - 9072

• Elaboración de directrices para la publicación de investigación biomédica: proceso y fundamento científico

  Altman DG. and Moher D., (2005), Medicina Clínica, 125, 8 - 13

• Do the left-handed die young?

  Altman D. and Bland M., (2005), Significance, 2, 166 - 170

• CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting.

  Halligan S. et al, (2005), Radiology, 237, 893 - 904

• [The CONSORT statement for cluster randomised trials].

  Campbell MK. et al, (2005), Medicina clinica, 125 Suppl 1, 28 - 31

• [Diagnostic (STARD) and prognostic (REMARK) studies].

  Altman DG. and Bossuyt PM., (2005), Medicina clinica, 125 Suppl 1, 49 - 55

• [Developing guidelines for reporting healthcare research: scientific rationale and procedures].

  Altman DG. and Moher D., (2005), Medicina clinica, 125 Suppl 1, 8 - 13

• Re: "Quality of reporting of observational longitudinal research"

  von Elm E. et al, (2005), AMERICAN JOURNAL OF EPIDEMIOLOGY, 162

• Re: "quality of reporting of observational longitudinal research".

  von Elm E. et al, (2005), American journal of epidemiology, 162, 1032 - 1033

• Standard deviations and standard errors.

  Altman DG. and Bland JM., (2005), BMJ (Clinical research ed.), 331

• Outcome selection bias in meta-analysis.

  Williamson PR. et al, (2005), Statistical methods in medical research, 14, 515 - 524

• Primer: an evidence-based approach to prognostic markers.

  Altman DG. and Riley RD., (2005), Nature clinical practice. Oncology, 2, 466 - 472

• Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales.

  O'Rourke K. and Altman DG., (2005), Statistics in medicine, 24, 2733 - 2742

• Reporting recommendations for tumor marker prognostic studies (REMARK).

  McShane LM. et al, (2005), Journal of the National Cancer Institute, 97, 1180 - 1184

• REporting recommendations for tumour MARKer prognostic studies (REMARK).

  McShane LM. et al, (2005), British Journal of Cancer, 93, 387 - 391

• REporting recommendations for tumor MARKer prognostic studies (REMARK).

  McShane LM. et al, (2005), Nature clinical practice. Oncology, 2, 416 - 422

• The Good Clinical Practice guideline: a bronze standard for clinical research.

  Grimes DA. et al, (2005), Lancet (London, England), 366, 172 - 174

• Indirect comparisons of competing interventions.

  Glenny AM. et al, (2005), Health technology assessment (Winchester, England), 9, 1 - iv

• Identification of clinically useful cancer prognostic factors: what are we missing?

  McShane LM. et al, (2005), Journal of the National Cancer Institute, 97, 1023 - 1025

• Unjustified restrictions on letters to the editor.

  Altman DG., (2005), PLoS medicine, 2, e126 - e152

• Why we need confidence intervals.

  Altman DG., (2005), World journal of surgery, 29, 554 - 556

• Risk stratification for in-hospital mortality in acutely decompensated heart failure.

  Royston P. and Altman DG., (2005), JAMA, 293, 2467 - 2468

• Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors.

  Altman DG., (2005), BMJ : British Medical Journal, 330, 1056 - 1057

• Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study.

  Pildal J. et al, (2005), BMJ : British Medical Journal, 330

• Treatment allocation by minimisation.

  Altman DG. and Bland JM., (2005), BMJ : British Medical Journal, 330

• Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials - Comment

  Altman DG., (2005), BIOMETRICAL JOURNAL, 47, 128 - 130

• Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors.

  Chan AW. and Altman DG., (2005), BMJ : British Medical Journal, 330

• Conduct and reporting of clinical research.

  Liu JL. and Altman DG., (2005), Science (New York, N.Y.), 308, 201 - 202

• Outcome reporting bias in government-funded RCTs - Reply

  Chan AW. et al, (2005), CANADIAN MEDICAL ASSOCIATION JOURNAL, 172, 857 - 857

• Issues in data monitoring and interim analysis of trials.

  Grant AM. et al, (2005), Health technology assessment (Winchester, England), 9, 1 - iv

• Epidemiology and reporting of randomised trials published in PubMed journals.

  Chan AW. and Altman DG., (2005), Lancet (London, England), 365, 1159 - 1162

• The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001.

  Moher D. et al, (2005), Explore (New York, N.Y.), 1, 40 - 45

• Data monitoring in randomized controlled trials: surveys of recent practice and policies.

  Clemens F. et al, (2005), Clinical trials (London, England), 2, 22 - 33

• [Randomization and comparison of final quality in clinical studies].

  Altman DG. and Doré CJ., (2005), Zeitschrift fur arztliche Fortbildung und Qualitatssicherung, 99, 629 - 634

• Better reporting of harms in randomized trials: an extension of the CONSORT statement.

  Ioannidis JP. et al, (2004), Annals of internal medicine, 141, 781 - 788

• Vitamins to prevent cancer: supplementary problems.

  Forman D. and Altman D., (2004), Lancet (London, England), 364, 1193 - 1194

• Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.

  Chan AW. et al, (2004), CMAJ : Canadian Medical Association Journal, 171, 735 - 740

• Improving design and analysis of research: lessons from clinical research.

  Altman DG., (2004), Alternatives to laboratory animals : ATLA, 32 Suppl 2, 31 - 39

• BMJ statistical errors

  Cole TJ., (2004), BMJ, 329, 462 - 462

• Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond.

  Moher D. et al, (2004), CMAJ : Canadian Medical Association Journal, 171, 349 - 350

• Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines.

  Burton A. and Altman DG., (2004), British Journal of Cancer, 91, 4 - 8

• Diagnostic tests 4: likelihood ratios.

  Deeks JJ. and Altman DG., (2004), BMJ : British Medical Journal, 329, 168 - 169

• Systematic review of pharmacological treatment of obsessive compulsive disorder (OCD) in adults

  Soomro GM. et al, (2004), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 7, S196 - S197

• Turning a blind eye: testing the success of blinding and the CONSORT statement.

  Altman DG. et al, (2004), BMJ (Clinical research ed.), 328

• The logrank test.

  Bland JM. and Altman DG., (2004), BMJ : British Medical Journal, 328

• Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

  Chan AW. et al, (2004), JAMA, 291, 2457 - 2465

• Design-a-trial: a rule-based decision support system for clinical trial design

  Nammuni K. et al, (2004), KNOWLEDGE-BASED SYSTEMS, 17, 121 - 129

• Confidence intervals illuminate absence of evidence.

  Altman D. and Bland JM., (2004), BMJ (Clinical research ed.), 328, 1016 - 1017

• CONSORT statement: extension to cluster randomised trials.

  Campbell MK. et al, (2004), BMJ : British Medical Journal, 328, 702 - 708

• Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials.

  Sydes MR. et al, (2004), Clinical trials (London, England), 1, 60 - 79

• Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study.

  Sydes MR. et al, (2004), Clinical trials (London, England), 1, 48 - 59

• Design-a-trial: A rule-based decision support system for clinical trial design

  Nammuni K. et al, (2004), APPLICATIONS AND INNOVATIONS IN INTELLIGENT SYSTEMS XI, PROCEEDINGS, 3 - 17

• Indirect comparison meta-analysis of aspirin therapy after coronary surgery.

  Lim E. et al, (2003), BMJ : British Medical Journal, 327

• The usefulness of ultrasound assessment of amniotic fluid in predicting adverse outcome in prolonged pregnancy: a prospective blinded observational study.

  Morris JM. et al, (2003), BJOG : an international journal of obstetrics and gynaecology, 110, 989 - 994

• Charts of fetal size: kidney and renal pelvis measurements.

  Chitty LS. and Altman DG., (2003), Prenatal diagnosis, 23, 891 - 897

• Survival analysis part IV: further concepts and methods in survival analysis.

  Clark TG. et al, (2003), British Journal of Cancer, 89, 781 - 786

• Measuring inconsistency in meta-analyses.

  Higgins JP. et al, (2003), BMJ : British Medical Journal, 327, 557 - 560

• Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.

  Bradburn MJ. et al, (2003), British Journal of Cancer, 89, 605 - 611

• Survival analysis part II: multivariate data analysis--an introduction to concepts and methods.

  Bradburn MJ. et al, (2003), British Journal of Cancer, 89, 431 - 436

• Survival analysis part I: basic concepts and first analyses.

  Clark TG. et al, (2003), British Journal of Cancer, 89, 232 - 238

• Applying the right statistics: analyses of measurement studies.

  Bland JM. and Altman DG., (2003), Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 22, 85 - 93

• Missing covariate data in the construction of prognostic models: A review of current approaches

  Burton A. and Altman DG., (2003), CONTROLLED CLINICAL TRIALS, 24, 212S - 212S

• Epidemiology of recent randomised controlled trials

  Chan AW. and Altman DG., (2003), CONTROLLED CLINICAL TRIALS, 24, 220S - 221S

• Empirical evidence for selective reporting of outcomes in randomised controlled trials

  Chan AW. and Altman DG., (2003), CONTROLLED CLINICAL TRIALS, 24, 64S - 64S

• A review of the methodology and reporting of multi-arm, parallel group, randomised clinical trials

  Juszczak E. et al, (2003), CONTROLLED CLINICAL TRIALS, 24, 150S - 151S

• New edicts for letters - Restrictions should not be imposed on post-publication peer review

  Altman DG., (2003), BRITISH MEDICAL JOURNAL, 326, 985 - 985

• Analysis and reporting of factorial trials: a systematic review.

  McAlister FA. et al, (2003), JAMA, 289, 2545 - 2553

• Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses.

  Song F. et al, (2003), BMJ (Clinical research ed.), 326

• The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

  Moher D. et al, (2003), Clinical oral investigations, 7, 2 - 7

• Interaction revisited: the difference between two estimates.

  Altman DG. and Bland JM., (2003), BMJ (Clinical research ed.), 326

• Evaluating non-randomised intervention studies.

  Deeks JJ. et al, (2003), Health technology assessment (Winchester, England), 7, iii - 173

• Developing a prognostic model in the presence of missing data: an ovarian cancer case study.

  Clark TG. and Altman DG., (2003), Journal of clinical epidemiology, 56, 28 - 37

• Reflections on medical journals.

  Moher D. et al, (2002), Annals of internal medicine, 137, 1011 - 1012

• CONSORT statement requires closer examination.

  Altman DG. et al, (2002), BMJ : British Medical Journal, 325

• Allocation concealment in clinical trials.

  Schulz KF. et al, (2002), JAMA, 288, 2406 - 2407

• Peer review of statistics in medical research - Reporting power calculations is important

  Altman DG. et al, (2002), BRITISH MEDICAL JOURNAL, 325, 492 - 492

• Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.

  Curtin F. et al, (2002), Statistics in medicine, 21, 2161 - 2173

• Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes.

  Curtin F. et al, (2002), Statistics in medicine, 21, 2145 - 2159

• Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.

  Curtin F. et al, (2002), Statistics in medicine, 21, 2131 - 2144

• Interpreting the number needed to treat.

  Schulz KF. et al, (2002), JAMA, 288

• Commentary: Systematic reviewers face challenges from varied study designs.

  Altman DG., (2002), BMJ : British Medical Journal, 325

• Charts of fetal size: limb bones.

  Chitty LS. and Altman DG., (2002), BJOG : an international journal of obstetrics and gynaecology, 109, 919 - 929

• The CONSORT statement: Explanation and elaboration - In response

  Egger M. et al, (2002), ANNALS OF INTERNAL MEDICINE, 136, 926 - 927

• Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.

  Sterne JA. et al, (2002), Statistics in medicine, 21, 1513 - 1524

• Poor-quality medical research: what can journals do?

  Altman DG., (2002), JAMA, 287, 2765 - 2767

• How statistical expertise is used in medical research.

  Altman DG. et al, (2002), JAMA, 287, 2817 - 2820

• Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls.

  Pocock SJ. et al, (2002), Lancet (London, England), 359, 1686 - 1689

• Commentary on quantifying agreement between two methods of measurement

  Altman DG. and Bland JM., (2002), CLINICAL CHEMISTRY, 48, 801 - 802

• Quantification of the completeness of follow-up.

  Clark TG. et al, (2002), Lancet (London, England), 359, 1309 - 1310

• Invited talk: 20 years of Burwalls.

  Altman D., (2002), Statistics in medicine, 21, 959 - 967

• Statistics Notes: Validating scales and indexes.

  Bland JM. and Altman DG., (2002), BMJ (Clinical research ed.), 324, 606 - 607

• Reporting the clinical importance of randomized controlled trials.

  Moher D. et al, (2002), CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 166, 711 - 712

• The landscape and lexicon of blinding in randomized trials.

  Schulz KF. et al, (2002), Annals of internal medicine, 136, 254 - 259

• Meta-analyses involving cross-over trials: methodological issues.

  Elbourne DR. et al, (2002), International journal of epidemiology, 31, 140 - 149

• Meta-analysis, Simpson's paradox, and the number needed to treat.

  Altman DG. and Deeks JJ., (2002), BMC medical research methodology, 2

• Bayesian stopping rules for trials - Reply

  Parmar MKB. et al, (2002), LANCET, 359, 76 - 77

• The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials

  Moher D. et al, (2002), ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 8, 96 - 100

• Reporting on statistical methods to adjust for confounding: a cross-sectional survey.

  Müllner M. et al, (2002), Annals of internal medicine, 136, 122 - 126

• Statistics notes: Analysing controlled trials with baseline and follow up measurements.

  Vickers AJ. and Altman DG., (2001), BMJ (Clinical research ed.), 323, 1123 - 1124

• Electronic patient records in general practice. Methods of evaluation of electronic patient records entail dangers.

  Newcombe RG. et al, (2001), BMJ (Clinical research ed.), 323, 1184 - 1185

• Authors should make their data available.

  Altman DG. and Cates C., (2001), BMJ : British Medical Journal, 323, 1069 - 1070

• A meta-analysis of hormone replacement therapy for fracture prevention.

  Altman DG., (2001), JAMA, 286, 2096 - 2097

• Ethical issues in the reporting of clinical trials - Reply

  Schulz KF. et al, (2001), JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 286, 1577 - 1578

• Ethical issues in the reporting of clinical trials [6] (multiple letters)

  Djulbegovic B. et al, (2001), Journal of the American Medical Association, 286, 1577 - 1578

• The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials (Reprinted from JAMA 2001;285:1987-1991)

  Moher D. et al, (2001), JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 193, A71 - A76

• Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries.

  Taggart DP. et al, (2001), Lancet (London, England), 358, 870 - 875

• A prognostic model for ovarian cancer.

  Clark TG. et al, (2001), British Journal of Cancer, 85, 944 - 952

• The efficacy of problem-solving treatments after deliberate self-harm: meta-analysis of randomized controlled trials with respect to depression, hopelessness and improvement in problems.

  Townsend E. et al, (2001), Psychological medicine, 31, 979 - 988

• Statistics notes: Concealing treatment allocation in randomised trials.

  Altman DG. and Schulz KF., (2001), BMJ : British Medical Journal, 323, 446 - 447

• Monitoring of large randomised clinical trials: a new approach with Bayesian methods.

  Parmar MK. et al, (2001), Lancet (London, England), 358, 375 - 381

• Systematic reviews of evaluations of prognostic variables.

  Altman DG., (2001), BMJ (Clinical research ed.), 323, 224 - 228

• Systematic reviews in health care: Assessing the quality of controlled clinical trials.

  Jüni P. et al, (2001), BMJ (Clinical research ed.), 323, 42 - 46

• The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

  Altman DG. et al, (2001), Annals of internal medicine, 134, 663 - 694

• The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

  Moher D. et al, (2001), Lancet (London, England), 357, 1191 - 1194

• The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

  Moher D. et al, (2001), Annals of internal medicine, 134, 657 - 662

• The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

  Moher D. et al, (2001), JAMA, 285, 1987 - 1991

• The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials.

  Moher D. et al, (2001), BMC medical research methodology, 1

• Challenges in evaluating complex decision support systems: Lessons from Design-a-Trial

  Potts HWW. et al, (2001), ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS, 2101, 453 - 456

• Statistics in medical journals: some recent trends.

  Altman DG., (2000), Statistics in medicine, 19, 3275 - 3289

• Randomisation in the SYMPHONY trial.

  Altman DG., (2000), Lancet (London, England), 356, 1521 - 1522

• Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery.

  Song F. et al, (2000), Controlled clinical trials, 21, 488 - 497

• Statistics notes: blinding in clinical trials and other studies.

  Day SJ. and Altman DG., (2000), BMJ (Clinical research ed.), 321

• The quality of systematic reviews. High quality reporting of both randomised trials and systematic reviews should be priority.

  Altman DG. et al, (2000), BMJ : British Medical Journal, 321

• Statistics notes. The odds ratio.

  Bland JM. and Altman DG., (2000), BMJ : British Medical Journal, 320

• Evidence for novel non-angiogenic pathway in breast-cancer metastasis. Breast Cancer Progression Working Party.

  (2000), Lancet (London, England), 355, 1787 - 1788

• What do we mean by validating a prognostic model?

  Altman DG. and Royston P., (2000), Statistics in medicine, 19, 453 - 473

• Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study.

  Bishop JA. et al, (2000), The British journal of dermatology, 142, 331 - 337

• ROC curves and confidence intervals: getting them right.

  Altman DG., (2000), Heart (British Cardiac Society), 83

• Modeling the effects of continuous risk factors.

  Royston P. et al, (2000), Journal of clinical epidemiology, 53, 219 - 221

• Number needed to treat: properties and problems - Comments

  Altman DG. et al, (2000), JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 163, 415 - 417

• Calculating the number needed to treat for trials where the outcome is time to an event.

  Altman DG. and Andersen PK., (1999), BMJ (Clinical research ed.), 319, 1492 - 1495

• The Cochrane Collaboration.

  Altman DG. and Burton MJ., (1999), Langenbeck's archives of surgery, 384, 432 - 436

• Numbers needed to treat derived from meta-analysis. Length of follow up is poorly reported.

  D'Amico R. et al, (1999), BMJ (Clinical research ed.), 319

• How to randomise.

  Altman DG. and Bland JM., (1999), BMJ (Clinical research ed.), 319, 703 - 704

• Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair.

  Carson JL. et al, (1999), Transfusion, 39, 694 - 700

• Statistics notes: variables and parameters.

  Altman DG. and Bland JM., (1999), BMJ (Clinical research ed.), 318

• Measuring agreement in method comparison studies.

  Bland JM. and Altman DG., (1999), Statistical methods in medical research, 8, 135 - 160

• Statistics notes. Treatment allocation in controlled trials: why randomise?

  Altman DG. and Bland JM., (1999), BMJ (Clinical research ed.), 318

• Randomised trials useful to find best methods of enhancing clinical practice.

  Wyatt JC. et al, (1999), BMJ (Clinical research ed.), 318

• Estimating sample sizes for continuous, binary, and ordinal outcomes in paired comparisons: practical hints.

  Julious SA. et al, (1999), Journal of biopharmaceutical statistics, 9, 241 - 251

• Effects of a drug overdose in a television drama on presentations to hospital for self poisoning: time series and questionnaire study.

  Hawton K. et al, (1999), BMJ : British Medical Journal, 318, 972 - 977

• Effects of a drug overdose in a television drama on knowledge of specific dangers of self poisoning: population based surveys.

  O'Connor S. et al, (1999), BMJ : British Medical Journal, 318, 978 - 979

• How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing.

  Chalmers I. and Altman DG., (1999), Lancet (London, England), 353, 490 - 493

• What randomized trials and systematic reviews can offer decision makers.

  Altman DG., (1999), Hormone research, 51 Suppl 1, 36 - 43

• Sensitivity and specificity and their confidence intervals cannot exceed 100%.

  Deeks JJ. and Altman DG., (1999), BMJ (Clinical research ed.), 318, 193 - 194

• Survival probabilities (the Kaplan-Meier method).

  Bland JM. and Altman DG., (1998), BMJ (Clinical research ed.), 317

• Statistical reviewing for medical journals.

  Altman DG., (1998), Statistics in medicine, 17, 2661 - 2674

• Inadequate reporting of controlled trials as short reports.

  Deeks JJ. and Altman DG., (1998), Lancet (London, England), 352

• Odds ratios should be avoided when events are common.

  Altman DG. et al, (1998), BMJ (Clinical research ed.), 317

• Confidence intervals for the number needed to treat.

  Altman DG., (1998), BMJ (Clinical research ed.), 317, 1309 - 1312

• Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units.

  Wyatt JC. et al, (1998), BMJ (Clinical research ed.), 317, 1041 - 1046

• Bayesians and frequentists.

  Bland JM. and Altman DG., (1998), BMJ (Clinical research ed.), 317, 1151 - 1160

• Time to event (survival) data.

  Altman DG. and Bland JM., (1998), BMJ (Clinical research ed.), 317, 468 - 469

• Suboptimal analysis using 'optimal' cutpoints.

  Altman DG., (1998), British journal of cancer, 78, 556 - 557

• Generalisation and extrapolation.

  Altman DG. and Bland JM., (1998), BMJ (Clinical research ed.), 317, 409 - 410

• Time trends in breast cancer survival: experience in a single centre, 1975-89.

  Bradburn MJ. et al, (1998), British journal of cancer, 77, 1944 - 1949

• Within trial variation--a false trail?

  Altman DG., (1998), Journal of clinical epidemiology, 51, 301 - 303

• The collaborative UK ECMO trial: Follow-up to 1 year of age

  Johnson A. et al, (1998), PEDIATRICS, 101

• Methodological challenges in the evaluation of prognostic factors in breast cancer.

  Altman DG. and Lyman GH., (1998), Breast cancer research and treatment, 52, 289 - 303

• Study to predict which elderly patients will fall shows difficulties in deriving and validating a model.

  Altman DG., (1997), BMJ (Clinical research ed.), 315

• What do children aged 5 to 11 years old know about the sun and skin cancer? The practical difficulties of international collaborative research when analysis of language is involved.

  Newton Bishop JA. et al, (1997), Melanoma research, 7, 428 - 435

• Risk of bacterial infection from allogeneic blood transfusion

  Carson JL. et al, (1997), TRANSFUSION, 37, S294 - S294

• New charts for ultrasound dating of pregnancy.

  Altman DG. and Chitty LS., (1997), Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 10, 174 - 191

• Difference versus mean plots.

  Bland JM. and Altman DG., (1997), Annals of clinical biochemistry, 34 ( Pt 5), 570 - 571

• Statistics notes. Units of analysis.

  Altman DG. and Bland JM., (1997), BMJ (Clinical research ed.), 314

• CONSORT statement on the reporting standards of clinical trials - Reply

  Altman DG. et al, (1997), BRITISH MEDICAL JOURNAL, 314, 1127 - 1127

• Cronbach's alpha.

  Bland JM. and Altman DG., (1997), BMJ (Clinical research ed.), 314

• Approximating statistical functions by using fractional polynomial regression

  Royston P. and Altman DG., (1997), STATISTICIAN, 46, 411 - 422

• Relation between treatment benefit and underlying risk in meta-analysis - Standard of ''label invariance'' should not abandoned - Reply

  Sharp S. et al, (1996), BRITISH MEDICAL JOURNAL, 313, 1550 - 1551

• Detecting skewness from summary information.

  Altman DG. and Bland JM., (1996), BMJ (Clinical research ed.), 313

• Correspondence Re: de Jong JS, van Diest PJ, and Baak JPA (1995). Methods in laboratory investigation: analysis of agreement rather than correlation in assessing heterogeneity and reproducibility of vessel counts in breast cancer.

  Lee AH. and Altman DG., (1996), Laboratory investigation; a journal of technical methods and pathology, 75, 755 - 758

• Interaction 3: How to examine heterogeneity.

  Matthews JN. and Altman DG., (1996), BMJ (Clinical research ed.), 313

• The relation between treatment benefit and underlying risk in meta-analysis.

  Sharp SJ. et al, (1996), BMJ (Clinical research ed.), 313, 735 - 738

• Statistics notes. Interaction 2: Compare effect sizes not P values.

  Matthews JN. and Altman DG., (1996), BMJ (Clinical research ed.), 313

• Measurement error.

  Bland JM. and Altman DG., (1996), BMJ (Clinical research ed.), 313

• Better reporting of randomised controlled trials: the CONSORT statement.

  Altman DG., (1996), BMJ (Clinical research ed.), 313, 570 - 571

• Statistics notes. Interaction 1: Heterogeneity of effects.

  Altman DG. and Matthews JN., (1996), BMJ (Clinical research ed.), 313

• Meta-analyses of randomised trials: when the whole is more than just the sum of the parts.

  Parmar MK. et al, (1996), British journal of cancer, 74, 496 - 501

• Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1978-1994.

  Oliver RT. et al, (1996), British journal of urology, 78, 119 - 124

• Measurement error proportional to the mean.

  Bland JM. and Altman DG., (1996), BMJ (Clinical research ed.), 313

• Measurement error and correlation coefficients.

  Bland JM. and Altman DG., (1996), BMJ (Clinical research ed.), 313, 41 - 42

• Comparing several groups using analysis of variance.

  Altman DG. and Bland JM., (1996), BMJ (Clinical research ed.), 312, 1472 - 1473

• The use of transformation when comparing two means.

  Bland JM. and Altman DG., (1996), BMJ (Clinical research ed.), 312

• Patients' preferences and randomised trials - Reply

  Silverman WA. and Altman DG., (1996), LANCET, 347, 1119 - 1119

• Transformations, means, and confidence intervals.

  Bland JM. and Altman DG., (1996), BMJ (Clinical research ed.), 312

• Statistics in the medical literature .2.

  Altman D., (1996), STATISTICS IN MEDICINE, 15, 559 - 559

• Transforming data.

  Bland JM. and Altman DG., (1996), BMJ (Clinical research ed.), 312

• Statistics notes. Logarithms.

  Bland JM. and Altman DG., (1996), BMJ (Clinical research ed.), 312

• Presentation of numerical data.

  Altman DG. and Bland JM., (1996), BMJ (Clinical research ed.), 312

• Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology.

  Schulz KF. et al, (1996), BMJ (Clinical research ed.), 312, 742 - 744

• Patients' preferences and randomised trials.

  Silverman WA. and Altman DG., (1996), Lancet (London, England), 347, 171 - 174

• More informative abstracts revisited.

  Haynes RB. et al, (1996), The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, 33, 1 - 9

• Interventions to improve adherence to reporting guidelines in health research: a scoping review protocol

  de Tena-Davila B. et al, BMJ Open

• Impact of measurement error and sample size on the performance of multivariable risk prediction models: a simulation study

  Vazquez Montes M. et al

• Donald Mainland: anatomist, educator, thinker, medical statistician, trialist, and rheumatologist

  Altman DG., JLL Bulletin: Commentaries on the history of treatment evaluation

• CONSORT extension for reporting within-person randomised trials

  Pandis N. et al, BMJ

• Clinical prediction models: a critical review of online risk calculators

  Ma J. et al

• Assessing the impact of handling missing data when validating a prognostic model.

  Ma J. et al

• A protocol to evaluate an online tool for early career peer reviewers assessing reports of randomized controlled trials

  Chauvin A. et al, BMJ Open

• A multi-centre programme into the evaluation of biomarkers suitable for use in patients with kidney and liver diseases

  Selby PJ. et al, Health Technology Assessment

Key Publications

• What do we mean by validating a prognostic model?

  Altman DG. and Royston P., (2000), Statistics in medicine, 19, 453 - 473

• Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

  Chan AW. et al, (2004), JAMA, 291, 2457 - 2465

• CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

  Moher D. et al, (2010), BMJ (Clinical research ed.), 340

• Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.

  Savović J. et al, (2012), Annals of internal medicine, 157, 429 - 438

• Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD).

  Collins GS. et al, (2015), Annals of internal medicine, 162, 735 - 736

Recent Publications

• GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research

  Staniszewska S. et al, (2017), BMJ, 358

• Body composition at birth and its relationship with neonatal anthropometric ratios: the newborn body composition study of the INTERGROWTH-21st project.

  Villar J. et al, (2017), Pediatric research, 82, 305 - 316

• Associations Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization Trial.

  Taggart DP. et al, (2017), Circulation, 136, 454 - 463

• Invited commentary: methodological issues in the design and analysis of randomised trials.

  Mansournia MA. and Altman DG., (2017), British journal of sports medicine

• Enhancing the usability of systematic reviews by improving the consideration and description of interventions.

  Hoffmann TC. et al, (2017), BMJ (Clinical research ed.), 358